These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Cayman Islands
|
N/A
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(I.R.S. Employer
Identification No.)
|
|
Title of Class
|
Name of Exchange on Which Registered
|
|
Class A ordinary shares,
$0.10 par value per share
|
The Nasdaq Stock Market LLC
|
|
Class A Ordinary Shares, $0.10 par value
|
31,111,432
|
|
Class B Ordinary Shares, $0.10 par value
|
6,254,895
|
|
(Class)
|
Outstanding as of February 17, 2017
|
|
|
|
Page
|
|
ITEM 1.
|
||
|
ITEM 1A.
|
||
|
ITEM 1B.
|
||
|
ITEM 2.
|
||
|
ITEM 3.
|
||
|
ITEM 4.
|
||
|
ITEM 5.
|
||
|
ITEM 6.
|
||
|
ITEM 7.
|
||
|
ITEM 7A.
|
||
|
ITEM 8.
|
||
|
ITEM 9.
|
||
|
ITEM 9A.
|
||
|
ITEM 9B.
|
||
|
ITEM 10.
|
||
|
ITEM 11.
|
||
|
ITEM 12.
|
||
|
ITEM 13.
|
||
|
ITEM 14.
|
||
|
ITEM 15.
|
||
|
|
|
|
|
|
●
|
Our results will likely fluctuate from period to period and may not be indicative of our long-term prospects;
|
|
|
|
|
|
|
●
|
If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected;
|
|
|
|
|
|
|
●
|
Our investment portfolio may be concentrated in a few large positions which could result in large losses;
|
|
|
|
|
|
|
●
|
The property and casualty reinsurance market may be affected by cyclical trends;
|
|
|
|
|
|
|
●
|
The effect of emerging claim and coverage issues on our business is uncertain;
|
|
|
|
|
|
|
●
|
Rating agencies may downgrade or withdraw either of our ratings;
|
|
|
|
|
|
|
●
|
We depend on DME Advisors, LP (“DME Advisors”), to implement our investment strategy;
|
|
|
|
|
|
|
●
|
Loss of key executives could adversely impact our ability to implement our business strategy; and
|
|
|
|
|
|
|
●
|
Currency fluctuations could result in exchange rate losses and negatively impact our business.
|
|
Reference
|
Entity’s legal name
|
|
Greenlight Capital Re
|
Greenlight Capital Re, Ltd.
|
|
Greenlight Re
|
Greenlight Reinsurance, Ltd.
|
|
GRIL
|
Greenlight Reinsurance Ireland, Designated Activity Company
|
|
Verdant
|
Verdant Holding Company, Ltd.
|
|
|
●
|
we aim to build a reinsurance portfolio comprised principally of high frequency and low severity contracts with favorable ultimate economic results measured after all loss payments have been made rather than focusing on interim reported results when losses may be incurred but not yet reported or paid;
|
|
|
|
|
|
|
●
|
we focus on offering customized reinsurance solutions to select customers at times and in markets where capacity and alternatives are limited rather than primarily pursuing and participating in broadly available traditional property and casualty opportunities;
|
|
|
|
|
|
|
●
|
we generally seek to act as the lead underwriter on a majority of the contracts we underwrite in an effort to obtain greater influence in negotiating pricing, terms and conditions. We may from time to time participate in contracts that have been negotiated and priced by another party. For example, on some longer duration casualty business that is comprised of larger, syndicated reinsurance placements, we may follow the market on these transactions;
|
|
|
|
|
|
|
●
|
we maintain a small group of experienced generalist underwriters that work in teams and that are capable of underwriting many lines of property and casualty business rather than a large staff of underwriters, each with an individual, specific focus on certain lines of business;
|
|
|
|
|
|
|
●
|
we implement a “cradle to grave” service philosophy where the same deal team underwrites and services each reinsurance contract rather than separating underwriting and servicing duties among many employees; and
|
|
|
|
|
|
|
●
|
we compensate our management with a cash bonus structure largely dependent on our underwriting results over a multi-year period rather than on premium volume or preliminary underwriting results in any given financial accounting period.
|
|
|
●
|
target markets where we believe capacity and alternatives are underserved or constrained;
|
|
|
|
|
|
|
●
|
seek clients with expertise in their respective lines of business;
|
|
|
|
|
|
|
●
|
employ strict underwriting discipline;
|
|
|
|
|
|
|
●
|
select reinsurance opportunities with anticipated favorable returns on capital over the life of the contract; and
|
|
|
|
|
|
|
●
|
strengthen and expand relationships with existing clients; including by making strategic investments from time to time.
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Property
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Commercial
|
|
$
|
16,180
|
|
|
3.0
|
%
|
|
$
|
15,633
|
|
|
3.1
|
%
|
|
$
|
11,826
|
|
|
3.6
|
%
|
|
Motor
|
|
39,551
|
|
|
7.4
|
|
|
34,529
|
|
|
6.9
|
|
|
24,008
|
|
|
7.4
|
|
|||
|
Personal
|
|
47,893
|
|
|
8.9
|
|
|
57,495
|
|
|
11.5
|
|
|
63,997
|
|
|
19.8
|
|
|||
|
Total Property
|
|
103,624
|
|
|
19.3
|
|
|
107,657
|
|
|
21.5
|
|
|
99,831
|
|
|
30.8
|
|
|||
|
Casualty
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
General Liability
|
|
34,450
|
|
|
6.4
|
|
|
27,620
|
|
|
5.5
|
|
|
11,234
|
|
|
3.5
|
|
|||
|
Motor
|
|
227,030
|
|
|
42.4
|
|
|
203,624
|
|
|
40.6
|
|
|
127,858
|
|
|
39.4
|
|
|||
|
Professional
|
|
37,847
|
|
|
7.1
|
|
|
65,607
|
|
|
13.1
|
|
|
26,129
|
|
|
8.1
|
|
|||
|
Workers' Compensation
|
|
25,456
|
|
|
4.7
|
|
|
12,646
|
|
|
2.5
|
|
|
730
|
|
|
0.2
|
|
|||
|
Total Casualty
|
|
324,783
|
|
|
60.6
|
|
|
309,497
|
|
|
61.7
|
|
|
165,951
|
|
|
51.2
|
|
|||
|
Specialty
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Accident & Health
|
|
52,114
|
|
|
9.7
|
|
|
56,784
|
|
|
11.3
|
|
|
43,837
|
|
|
13.5
|
|
|||
|
Financial
|
|
34,658
|
|
|
6.5
|
|
|
6,699
|
|
|
1.3
|
|
|
5,067
|
|
|
1.6
|
|
|||
|
Marine
|
|
9,127
|
|
|
1.7
|
|
|
9,283
|
|
|
1.8
|
|
|
5,120
|
|
|
1.6
|
|
|||
|
Other
|
|
11,766
|
|
|
2.2
|
|
|
12,204
|
|
|
2.4
|
|
|
4,217
|
|
|
1.3
|
|
|||
|
Total Specialty
|
|
107,665
|
|
|
20.1
|
|
|
84,970
|
|
|
16.8
|
|
|
58,241
|
|
|
18.0
|
|
|||
|
|
|
$
|
536,072
|
|
|
100.0
|
%
|
|
$
|
502,124
|
|
|
100.0
|
%
|
|
$
|
324,023
|
|
|
100.0
|
%
|
|
*
During the year ended December 31, 2016, the Company revised its classification of its lines of business. As a result, the gross written premiums in the above table relating to certain lines of business previously reported for the years ended December 31, 2015 and 2014, have been reclassified to conform to the current period presentation.
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
U.S. and Caribbean
|
|
$
|
432,144
|
|
|
80.6
|
%
|
|
$
|
383,236
|
|
|
76.3
|
%
|
|
$
|
275,402
|
|
|
85.0
|
%
|
|
Worldwide
(1)
|
|
97,810
|
|
|
18.2
|
|
|
104,336
|
|
|
20.8
|
|
|
31,106
|
|
|
9.6
|
|
|||
|
Europe
|
|
6,250
|
|
|
1.2
|
|
|
14,085
|
|
|
2.8
|
|
|
17,432
|
|
|
5.4
|
|
|||
|
Asia
(2)
|
|
(132
|
)
|
|
—
|
|
|
467
|
|
|
0.1
|
|
|
83
|
|
|
—
|
|
|||
|
|
|
$
|
536,072
|
|
|
100.0
|
%
|
|
$
|
502,124
|
|
|
100.0
|
%
|
|
$
|
324,023
|
|
|
100.0
|
%
|
|
(1)
|
“Worldwide” is comprised of contracts that reinsure risks in more than one geographic area and do not specifically exclude the U.S.
|
|
(2)
|
The negative balance represents reversal of premiums due to premium adjustments, termination of contracts or premium returned upon novation or commutation of contracts.
|
|
|
●
|
customized solutions that address the specific business needs of our clients;
|
|
|
●
|
rapid and substantive responses to proposal and pricing quote requests;
|
|
|
●
|
timely payment of claims;
|
|
|
●
|
financial security; and
|
|
|
●
|
clear indication of risks we will and will not underwrite.
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Largest broker
|
|
$
|
274,816
|
|
|
51.3
|
%
|
|
$
|
278,003
|
|
|
55.4
|
%
|
|
$
|
161,405
|
|
|
49.8
|
%
|
|
2nd largest broker
|
|
104,684
|
|
|
19.5
|
|
|
110,246
|
|
|
22.0
|
|
|
61,809
|
|
|
19.1
|
|
|||
|
3rd largest broker
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
40,773
|
|
|
12.6
|
|
|||
|
|
|
$
|
379,500
|
|
|
70.8
|
%
|
|
$
|
388,249
|
|
|
77.4
|
%
|
|
$
|
263,987
|
|
|
81.5
|
%
|
|
|
●
|
pay our clients a commission based upon a predetermined percentage of the profit we realize on the business, which we refer to as a profit commission;
|
|
|
●
|
provide that the client pays a predetermined amount of all losses before our reinsurance policy incurs a loss payment, which we refer to as self-insured retentions;
|
|
|
●
|
provide that the client pays a predetermined proportion of all losses above a predetermined amount, which we refer to as co-participation; and/or
|
|
|
●
|
charge the client a premium for reinstatement of reinsurance coverage to the full amount, which we refer to as reinstatement premium, if coverage has been reduced as a result of a reinsurance loss payment.
|
|
|
●
|
the client’s and industry’s historical loss data;
|
|
|
●
|
the expected duration for claims to fully develop;
|
|
|
●
|
the client’s pricing and underwriting strategies;
|
|
|
●
|
the geographic areas in which the client is doing business and its market share;
|
|
|
●
|
the reputation and financial strength of the client;
|
|
|
●
|
the reputation and expertise of the broker;
|
|
|
●
|
the likelihood of establishing a long-term relationship with the client and the broker; and
|
|
|
●
|
reports provided by independent industry specialists.
|
|
|
●
|
to maintain capital and a margin of solvency in accordance with the capital and solvency requirements prescribed by the Law;
|
|
|
|
|
|
|
●
|
to carry on its business in accordance with the terms of the license application submitted to CIMA and to seek the prior approval of CIMA for any proposed change thereto;
|
|
|
|
|
|
|
●
|
to maintain adequate arrangements for the management of risks and a system of governance as approved by CIMA;
|
|
|
|
|
|
|
●
|
to maintain a minimum of at least two directors and to seek the prior approval of CIMA in respect of the appointment of directors and officers and to provide CIMA with information in connection therewith and notification of any changes thereto;
|
|
|
|
|
|
|
●
|
to have a place of business in the Cayman Islands and to maintain such resources, including staff and facilities, books and records as CIMA considers appropriate having regard for the nature and scale of the business of Greenlight Re;
|
|
|
|
|
|
|
●
|
to submit to CIMA an annual return in the prescribed form together with:
|
|
|
|
1. financial statements prepared in accordance with any internationally recognized accounting standards, audited by an independent auditor approved by CIMA;
|
|
|
|
2. an actuarial valuation of Greenlight Re’s assets and liabilities, certified by an actuary approved by CIMA;
|
|
|
|
3. certification of solvency prepared by a person approved by CIMA in accordance with the prescribed requirements;
|
|
|
|
4. confirmation that the information contained in Greenlight Re’s license application, as modified by any subsequent changes, remains correct;
|
|
|
|
5. such other information as may be prescribed by CIMA; and
|
|
|
|
|
|
|
●
|
to pay an annual license fee.
|
|
|
●
|
to maintain a general review of insurance practices in the Cayman Islands;
|
|
|
|
|
|
|
●
|
to examine the affairs or business of any licensee or other person carrying on, or who has carried on, insurance business in order to ensure that the Law has been complied with and that the licensee is in a sound financial position and is carrying on its business in a fit and proper manner;
|
|
|
|
|
|
|
●
|
to examine and report on the annual returns delivered to CIMA in terms of the Law; and
|
|
|
|
|
|
|
●
|
to examine and make recommendations with respect to, among other things, proposals for the revocation of licenses and cases of suspected insolvency of licensed entities.
|
|
|
●
|
a material violation of applicable law relating to DME’s or DME Advisors’ advisory business;
|
|
|
|
|
|
|
●
|
DME’s or DME Advisors’ gross negligence, willful misconduct or reckless disregard of any of DME’s obligations under the venture agreement or DME Advisors’ obligations under the advisory agreement;
|
|
|
|
|
|
|
●
|
a material breach by DME or DME Advisors of Greenlight Re’s or GRIL’s investment guidelines that is not cured within a 15-day period; or
|
|
|
|
|
|
|
●
|
a material breach by DME or DME Advisors of its obligations to return and deliver assets as we may request.
|
|
|
●
|
Composition of Investments:
At least 80% of the assets in the investment portfolio will be held in debt or equity securities (including swaps) of publicly-traded companies (or their subsidiaries), governments of the Organization of Economic Co-operation and Development, (the “OECD”) and high income countries, cash, cash equivalents and gold. No more than 10% of the assets in the investment portfolio will be held in private equity securities.
|
|
|
|
|
|
|
●
|
Concentration of Investments:
Other than cash, cash equivalents, United States government obligations and gold, no single investment in the investment portfolio will constitute more than 20% of the portfolio.
|
|
|
|
|
|
|
●
|
Liquidity:
Assets will be invested in such fashion that Greenlight Re has a reasonable expectation that it can meet any of its liabilities as they become due. Greenlight Re will review with the investment advisor the liquidity of the portfolio on a periodic basis.
|
|
|
|
|
|
|
●
|
Monitoring:
Greenlight Re will require the investment advisor to re-evaluate each position in the investment portfolio and to monitor changes in intrinsic value and trading value and provide monthly reports on the investment portfolio to Greenlight Re as Greenlight Re may reasonably determine.
|
|
|
|
|
|
|
●
|
Leverage:
The investment portfolio may not employ greater than 15% indebtedness for borrowed money, including net margin balances, for extended time periods. The investment advisor may employ, in the normal course of business, up to 30% indebtedness for periods of less than 30 days.
|
|
|
|
|
|
|
|
Currency hedging activities are excluded from leverage calculations. Where the investment advisor enters into a secondary investment with the primary purpose of reducing the risk of another existing investment then the investment advisor may exclude the secondary investment from the calculation of leverage provided that the investment advisor receives approval from the Company’s Chief Financial Officer. Such authority is limited such that no more than 10% of indebtedness may be excluded from leverage calculations for such secondary investments.
|
|
|
●
|
Concentration of Investments:
Other than cash, cash equivalents and United States government obligations, (1) no single investment in the investment portfolio will constitute more than 10% of the portfolio, (2) the 10 largest investments shall not constitute greater than 50% of the total investment portfolio, and (3) the investment portfolio shall at all times be comprised of a minimum of 50 debt or equity securities of publicly traded companies (or their subsidiaries).
|
|
|
|
|
|
|
●
|
Credit default swaps:
The sale of credit default swaps is prohibited.
|
|
|
|
|
|
|
●
|
Leverage:
The investment portfolio may not employ greater than 5% indebtedness for borrowed money, including net margin balances, for extended time periods. The investment advisor may use, in the normal course of business, an aggregate of up to 20% net margin leverage for periods of less than 30 days.
|
|
|
|
December 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Debt instruments
|
|
$
|
22,473
|
|
|
2.0
|
%
|
|
$
|
39,087
|
|
|
3.3
|
%
|
|
Equities – listed
|
|
828,486
|
|
|
74.0
|
|
|
890,653
|
|
|
76.2
|
|
||
|
Exchange traded funds
|
|
15,515
|
|
|
1.4
|
|
|
15,341
|
|
|
1.3
|
|
||
|
Commodities
|
|
137,296
|
|
|
12.3
|
|
|
98,046
|
|
|
8.4
|
|
||
|
Private and unlisted equity securities
|
|
18,767
|
|
|
1.7
|
|
|
21,037
|
|
|
1.8
|
|
||
|
|
|
1,022,537
|
|
|
91.4
|
|
|
1,064,164
|
|
|
91.0
|
|
||
|
Funds and cash held with brokers and swap counterparties
|
|
22,541
|
|
|
2.0
|
|
|
120,276
|
|
|
10.3
|
|
||
|
Financial contracts, net
|
|
74,144
|
|
|
6.6
|
|
|
(15,030
|
)
|
|
(1.3
|
)
|
||
|
Total long investments
|
|
$
|
1,119,222
|
|
|
100.0
|
%
|
|
$
|
1,169,410
|
|
|
100.0
|
%
|
|
|
|
December 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Equities – listed
|
|
$
|
770,267
|
|
|
89.6
|
%
|
|
$
|
796,054
|
|
|
90.2
|
%
|
|
Exchange traded funds
|
|
—
|
|
|
—
|
|
|
12,427
|
|
|
1.4
|
|
||
|
Sovereign debt – Non U.S.
|
|
89,635
|
|
|
10.4
|
|
|
74,425
|
|
|
8.4
|
|
||
|
Total short investments
|
|
$
|
859,902
|
|
|
100.0
|
%
|
|
$
|
882,906
|
|
|
100.0
|
%
|
|
|
|
December 31
|
||||||||||
|
|
|
2016
|
|
2015
|
||||||||
|
|
|
Long %
|
|
Short %
|
|
Long %
|
|
Short %
|
||||
|
Debt instruments
|
|
1.9
|
%
|
|
—
|
%
|
|
1.9
|
%
|
|
—
|
%
|
|
Equities & related derivatives
|
|
96.3
|
|
|
(72.9
|
)
|
|
86.0
|
|
|
(74.0
|
)
|
|
Private and unlisted equity securities
|
|
1.3
|
|
|
—
|
|
|
1.6
|
|
|
—
|
|
|
Total
|
|
99.5
|
%
|
|
(72.9
|
)%
|
|
89.5
|
%
|
|
(74.0
|
)%
|
|
Sector
|
|
Long %
|
|
Short %
|
|
Net %
|
|||
|
Basic Materials
|
|
8.7
|
%
|
|
(3.5
|
)%
|
|
5.2
|
%
|
|
Consumer Cyclical
|
|
33.1
|
|
|
(12.7
|
)
|
|
20.4
|
|
|
Consumer Non-Cyclical
|
|
2.2
|
|
|
(0.6
|
)
|
|
1.6
|
|
|
Energy
|
|
7.6
|
|
|
(13.7
|
)
|
|
(6.1
|
)
|
|
Financial
|
|
11.9
|
|
|
(9.4
|
)
|
|
2.5
|
|
|
Healthcare
|
|
10.6
|
|
|
(7.6
|
)
|
|
3.0
|
|
|
Industrial
|
|
9.2
|
|
|
(15.6
|
)
|
|
(6.4
|
)
|
|
Technology
|
|
10.0
|
|
|
(9.7
|
)
|
|
0.3
|
|
|
Utilities
|
|
6.2
|
|
|
(0.1
|
)
|
|
6.1
|
|
|
Total
|
|
99.5
|
%
|
|
(72.9
|
)%
|
|
26.6
|
%
|
|
Capitalization
|
|
Long %
|
|
Short %
|
|
Net %
|
|||
|
Mega Cap Equity (≥$25 billion)
|
|
42.0
|
%
|
|
(28.2
|
)%
|
|
13.8
|
%
|
|
Large Cap Equity (≥$5 billion and <$25 billion)
|
|
33.7
|
|
|
(32.9
|
)
|
|
0.8
|
|
|
Mid Cap Equity (≥$1 billion and <$5 billion)
|
|
15.0
|
|
|
(11.8
|
)
|
|
3.2
|
|
|
Small Cap Equity (<$1 billion)
|
|
5.6
|
|
|
—
|
|
|
5.6
|
|
|
Debt Instruments
|
|
1.9
|
|
|
—
|
|
|
1.9
|
|
|
Other Investments
|
|
1.3
|
|
|
—
|
|
|
1.3
|
|
|
Total
|
|
99.5
|
%
|
|
(72.9
|
)%
|
|
26.6
|
%
|
|
|
|
Year ended December 31
|
||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Realized gains (losses)
|
|
$
|
(113,836
|
)
|
|
$
|
22,227
|
|
|
$
|
352,133
|
|
|
Change in unrealized gains and losses
|
|
209,993
|
|
|
(265,401
|
)
|
|
(187,753
|
)
|
|||
|
Investment related foreign exchange gains (losses)
|
|
2,988
|
|
|
(3,725
|
)
|
|
14,797
|
|
|||
|
Interest and dividend income, net of withholding taxes
|
|
23,915
|
|
|
15,313
|
|
|
31,423
|
|
|||
|
Interest, dividend and other expenses
|
|
(22,334
|
)
|
|
(31,092
|
)
|
|
(38,892
|
)
|
|||
|
Investment advisor compensation
|
|
(24,543
|
)
|
|
(19,246
|
)
|
|
(49,133
|
)
|
|||
|
Net investment income (loss)
|
|
$
|
76,183
|
|
|
$
|
(281,924
|
)
|
|
$
|
122,575
|
|
|
Quarter
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|||||
|
1st
|
|
2.5
|
%
|
|
(1.8
|
)%
|
|
(0.7
|
)%
|
|
5.8
|
%
|
|
6.5
|
%
|
|
2nd
|
|
(3.4
|
)
|
|
(1.5
|
)
|
|
8.1
|
|
|
2.0
|
|
|
(3.3
|
)
|
|
3rd
|
|
3.1
|
|
|
(14.2
|
)
|
|
(3.7
|
)
|
|
4.0
|
|
|
8.8
|
|
|
4th
|
|
5.0
|
|
|
(4.0
|
)
|
|
5.3
|
|
|
6.6
|
|
|
(4.4
|
)
|
|
Full Year
|
|
7.2
|
%
|
|
(20.2
|
)%
|
|
8.7
|
%
|
|
19.6
|
%
|
|
7.1
|
%
|
|
|
●
|
reinsurance contract pricing;
|
|
|
●
|
our assessment of the quality of available reinsurance opportunities;
|
|
|
●
|
the volume and mix of reinsurance products we underwrite;
|
|
|
●
|
loss experience on our reinsurance liabilities;
|
|
|
●
|
the performance of our investment portfolio; and
|
|
|
●
|
our ability to assess and integrate our risk management strategy properly.
|
|
|
●
|
premium charges;
|
|
|
●
|
ability to obtain terms and conditions appropriate with the risk being assumed and in accordance with our underwriting guidelines;
|
|
|
●
|
the general reputation and perceived financial strength of the reinsurer;
|
|
|
●
|
relationships with reinsurance brokers;
|
|
|
●
|
ratings assigned by independent rating agencies;
|
|
|
●
|
speed of claims payment and reputation; and
|
|
|
●
|
the experience and reputation of the members of our underwriting team in the particular lines of reinsurance we seek to underwrite.
|
|
|
●
|
if we change our business practices from our organizational business plan in a manner that no longer supports our A.M. Best ratings;
|
|
|
●
|
if unfavorable financial or market trends impact us;
|
|
|
●
|
if our actual losses significantly exceed our loss reserves;
|
|
|
●
|
if A.M. Best alters its capital adequacy assessment methodology in a manner that would adversely affect the rating of either reinsurer;
|
|
|
●
|
if we are unable to retain our senior management and other key personnel; or
|
|
|
●
|
if our investment portfolio incurs significant losses.
|
|
|
●
|
the lapse of time from the occurrence of an event to the reporting of the claim and the ultimate resolution or settlement of the claim;
|
|
|
●
|
the diversity of development patterns among different types of reinsurance treaties; and
|
|
|
●
|
the necessary reliance on the client for information regarding claims.
|
|
|
●
|
fund liquidity needs caused by underwriting or investment losses;
|
|
|
●
|
replace capital lost in the event of significant reinsurance losses or adverse reserve developments or significant investment losses;
|
|
|
●
|
satisfy collateral requirements that may be imposed by our clients or by regulators;
|
|
|
●
|
meet applicable statutory jurisdiction requirements;
|
|
|
●
|
meet rating agency capital requirements; or
|
|
|
●
|
respond to competitive pressures.
|
|
|
●
|
we cease to carry on reinsurance business;
|
|
|
●
|
the direction and management of our reinsurance business has not been conducted in a fit and proper manner;
|
|
|
●
|
a person holding a position as a director, manager or officer is not a fit and proper person to hold the respective position; or
|
|
|
●
|
we become bankrupt or go into liquidation or we are wound up or otherwise dissolved.
|
|
|
●
|
a 1.5% annual management fee to DME Advisors, regardless of the performance of our investment account, payable monthly based on the capital account balance of each participant; and
|
|
|
|
|
|
|
●
|
a performance allocation to DME based on the positive performance change in such participant’s capital account equal to 20% of net profits calculated per annum, subject to a loss carry forward provision.
|
|
|
●
|
a material violation of applicable law relating to DME’s or DME Advisors’ advisory business;
|
|
|
●
|
DME’s or DME Advisors’ gross negligence, willful misconduct or reckless disregard of DME’s obligations under the venture agreement or DME Advisors’ obligations under the advisory agreement;
|
|
|
●
|
a material breach by DME or DME Advisors of Greenlight Re’s or GRIL’s investment guidelines that is not cured within a 15-day period; or
|
|
|
●
|
a material breach by DME or DME Advisors of its obligations to return and deliver assets as we may request.
|
|
|
●
|
the statutory provisions as to majority vote have been complied with;
|
|
|
|
|
|
|
●
|
the shareholders have been fairly represented at the meeting in question;
|
|
|
|
|
|
|
●
|
the scheme of arrangement is such as a businessman would reasonably approve; and
|
|
|
|
|
|
|
●
|
the scheme of arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law.
|
|
|
●
|
our gross income attributable to insurance or reinsurance policies where the direct or indirect insureds are our direct or indirect United States shareholders or persons related to such United States shareholders equals or exceeds 20% of our gross insurance income in any taxable year; and
|
|
|
●
|
direct or indirect insureds and persons related to such insureds owned directly or indirectly 20% or more of the voting power or value of our stock,
|
|
|
|
2016
|
|
2015
|
||||||||||||
|
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||
|
First Quarter
|
|
$
|
22.13
|
|
|
$
|
16.05
|
|
|
$
|
33.23
|
|
|
$
|
30.42
|
|
|
Second Quarter
|
|
$
|
22.07
|
|
|
$
|
18.79
|
|
|
$
|
31.91
|
|
|
$
|
29.14
|
|
|
Third Quarter
|
|
$
|
21.86
|
|
|
$
|
18.97
|
|
|
$
|
30.05
|
|
|
$
|
22.13
|
|
|
Fourth Quarter
|
|
$
|
24.10
|
|
|
$
|
19.25
|
|
|
$
|
25.20
|
|
|
$
|
17.86
|
|
|
|
|
Year ended December 31
|
||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
|
|
|
($ in thousands, except per share and share amounts)
|
||||||||||||||||||
|
Selected Consolidated Statement of Income Data
|
|
|
||||||||||||||||||
|
Gross premiums written
|
|
$
|
536,072
|
|
|
$
|
502,124
|
|
|
$
|
324,023
|
|
|
$
|
535,702
|
|
|
$
|
427,844
|
|
|
Net premiums earned
|
|
513,118
|
|
|
408,387
|
|
|
354,240
|
|
|
547,899
|
|
|
466,714
|
|
|||||
|
Net investment income (loss)
|
|
76,183
|
|
|
(281,924
|
)
|
|
122,575
|
|
|
218,140
|
|
|
78,941
|
|
|||||
|
Loss and loss adjustment expenses incurred, net
|
|
380,815
|
|
|
317,097
|
|
|
234,986
|
|
|
338,493
|
|
|
366,601
|
|
|||||
|
Acquisition costs, net
|
|
134,534
|
|
|
116,207
|
|
|
107,665
|
|
|
171,872
|
|
|
142,721
|
|
|||||
|
General and administrative expenses
|
|
25,808
|
|
|
23,434
|
|
|
24,500
|
|
|
20,958
|
|
|
16,755
|
|
|||||
|
Net income (loss)
|
|
$
|
44,881
|
|
|
$
|
(326,425
|
)
|
|
$
|
109,592
|
|
|
$
|
225,699
|
|
|
$
|
14,598
|
|
|
Earnings (Loss) Per Share Data
(1)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
$
|
1.20
|
|
|
$
|
(8.90
|
)
|
|
$
|
2.94
|
|
|
$
|
6.13
|
|
|
$
|
0.40
|
|
|
Diluted
|
|
1.20
|
|
|
(8.90
|
)
|
|
2.89
|
|
|
6.01
|
|
|
0.39
|
|
|||||
|
Weighted average number of ordinary shares used in the determination of earnings and loss per share
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
37,267,145
|
|
|
36,670,466
|
|
|
37,242,687
|
|
|
36,838,128
|
|
|
36,702,128
|
|
|||||
|
Diluted
|
|
37,340,018
|
|
|
36,670,466
|
|
|
37,874,387
|
|
|
37,585,167
|
|
|
37,361,338
|
|
|||||
|
Underwriting Income (Loss) and Selected Ratios
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Underwriting income (loss) *
|
|
$
|
(18,814
|
)
|
|
$
|
(41,909
|
)
|
|
$
|
(4,908
|
)
|
|
$
|
22,311
|
|
|
$
|
(53,315
|
)
|
|
Loss ratio
(2)
|
|
74.2
|
%
|
|
77.6
|
%
|
|
66.3
|
%
|
|
61.8
|
%
|
|
78.5
|
%
|
|||||
|
Acquisition cost ratio
(3)
|
|
26.2
|
%
|
|
28.5
|
%
|
|
30.4
|
%
|
|
31.4
|
%
|
|
30.6
|
%
|
|||||
|
Underwriting expense ratio
(4)
|
|
3.2
|
%
|
|
4.2
|
%
|
|
4.7
|
%
|
|
2.8
|
%
|
|
2.3
|
%
|
|||||
|
Combined ratio
(5)
|
|
103.6
|
%
|
|
110.3
|
%
|
|
101.4
|
%
|
|
96.0
|
%
|
|
111.4
|
%
|
|||||
|
|
|
December 31
|
||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
|
|
|
($ in thousands, except per share and share amounts)
|
||||||||||||||||||
|
Selected Consolidated Balance Sheet Data
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total investments
|
|
$
|
1,022,537
|
|
|
$
|
1,064,164
|
|
|
$
|
1,430,978
|
|
|
$
|
1,393,679
|
|
|
$
|
1,177,928
|
|
|
Cash and cash equivalents
|
|
39,858
|
|
|
112,162
|
|
|
12,030
|
|
|
3,722
|
|
|
21,890
|
|
|||||
|
Restricted cash and cash equivalents
|
|
1,202,651
|
|
|
1,236,589
|
|
|
1,296,914
|
|
|
1,334,074
|
|
|
1,206,837
|
|
|||||
|
Total assets
|
|
2,664,693
|
|
|
2,712,522
|
|
|
2,995,292
|
|
|
3,095,276
|
|
|
2,722,753
|
|
|||||
|
Securities sold, not yet purchased, at fair value
|
|
859,902
|
|
|
882,906
|
|
|
1,090,731
|
|
|
1,111,690
|
|
|
908,368
|
|
|||||
|
Due to prime brokers
|
|
319,830
|
|
|
396,453
|
|
|
211,070
|
|
|
314,702
|
|
|
326,488
|
|
|||||
|
Loss and loss adjustment expense reserves ^
|
|
306,641
|
|
|
305,997
|
|
|
264,243
|
|
|
329,894
|
|
|
356,470
|
|
|||||
|
Unearned premium reserves
|
|
222,527
|
|
|
211,954
|
|
|
128,736
|
|
|
173,057
|
|
|
188,185
|
|
|||||
|
Total liabilities
|
|
1,773,006
|
|
|
1,863,749
|
|
|
1,801,251
|
|
|
2,008,972
|
|
|
1,862,343
|
|
|||||
|
Total equity
|
|
891,687
|
|
|
848,773
|
|
|
1,194,041
|
|
|
1,086,304
|
|
|
860,410
|
|
|||||
|
Adjusted book value*
(6)
|
|
874,242
|
|
|
825,391
|
|
|
1,165,151
|
|
|
1,051,595
|
|
|
821,708
|
|
|||||
|
Diluted adjusted book value*
(7)
|
|
$
|
876,362
|
|
|
$
|
836,944
|
|
|
$
|
1,184,779
|
|
|
$
|
1,067,623
|
|
|
$
|
840,683
|
|
|
Ordinary shares outstanding
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
37,366,327
|
|
|
37,027,467
|
|
|
37,384,543
|
|
|
37,046,814
|
|
|
36,702,128
|
|
|||||
|
Diluted
(8)
|
|
37,489,647
|
|
|
37,744,807
|
|
|
38,516,460
|
|
|
38,257,545
|
|
|
38,193,418
|
|
|||||
|
Per Share Data
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic adjusted book value per share*
(9)
|
|
$
|
23.40
|
|
|
$
|
22.29
|
|
|
$
|
31.17
|
|
|
$
|
28.39
|
|
|
$
|
22.39
|
|
|
Fully diluted adjusted book value per share*
(10)
|
|
23.38
|
|
|
22.17
|
|
|
30.76
|
|
|
27.91
|
|
|
22.01
|
|
|||||
|
(1)
|
Basic earnings per share is calculated by dividing net income by the weighted average number of common shares and participating securities outstanding for the period. Diluted earnings per share is calculated by taking into account the effects of exercising all dilutive stock options. In the event of a net loss, any stock options outstanding are excluded from the calculation of diluted loss per share. Unvested stock awards which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid (referred to as “participating securities”) are included in the number of shares outstanding for both basic and diluted earnings per share calculations. In the event of a net loss, the participating securities are excluded from both basic and diluted loss per share.
|
|
(2)
|
The loss ratio is calculated by dividing net loss and loss adjustment expenses incurred by net premiums earned.
|
|
(3)
|
The acquisition cost ratio is calculated by dividing net acquisition costs by net premiums earned.
|
|
(4)
|
The underwriting expense ratio is the ratio of underwriting expenses to net premiums earned.
|
|
(5)
|
The combined ratio is the sum of the loss ratio, acquisition cost ratio and underwriting expense ratio.
|
|
(6)
|
Adjusted book value equals total equity minus non-controlling interest in joint venture.
|
|
(7)
|
Diluted adjusted book value is the adjusted book value plus the proceeds from the exercise of in-the-money options issued and outstanding at year end.
|
|
(8)
|
Diluted number of shares outstanding is the sum of basic shares outstanding and the in-the-money options and restricted stock units issued and outstanding at year end.
|
|
(9)
|
Basic adjusted book value per share is calculated by dividing adjusted book value by the number of shares and share equivalents issued and outstanding at year end.
|
|
(10)
|
Fully diluted adjusted book value per share is calculated by dividing the diluted adjusted book value by the diluted number of shares outstanding at year end.
|
|
*
|
Adjusted book value, diluted adjusted book value, basic adjusted book value per share, fully diluted adjusted book value per share and underwriting income (loss) are non-GAAP measures. For a reconciliation of the non-GAAP measures to the most comparable GAAP measures, refer to “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Results of Operations”.
|
|
^
|
For detailed discussion of change in loss and loss adjustment expenses, refer to “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Financial Condition” and Note 7 to the consolidated financial statements.
|
|
|
●
|
frequency business; and
|
|
|
●
|
severity business.
|
|
|
●
|
premiums from reinsurance on property and casualty business assumed; and
|
|
|
●
|
income from investments.
|
|
|
●
|
underwriting losses and loss adjustment expenses;
|
|
|
●
|
acquisition costs;
|
|
|
●
|
investment-related expenses; and
|
|
|
●
|
general and administrative expenses.
|
|
•
|
Basic adjusted book value per share;
|
|
•
|
Fully diluted adjusted book value per share;
|
|
•
|
Net underwriting income (loss);
|
|
|
December 31, 2016
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||
|
|
($ in thousands, except per share and share amounts)
|
||||||||||
|
Basic adjusted and fully diluted adjusted book value per share numerator:
|
|
|
|
|
|
||||||
|
Total equity (U.S. GAAP)
|
$
|
891,687
|
|
|
$
|
848,773
|
|
|
$
|
1,194,041
|
|
|
Less: Non-controlling interest in joint venture
|
(17,445
|
)
|
|
(23,382
|
)
|
|
(28,890
|
)
|
|||
|
Basic adjusted book value per share numerator
|
874,242
|
|
|
825,391
|
|
|
1,165,151
|
|
|||
|
Add: Proceeds from in-the-money stock options issued and outstanding
|
2,120
|
|
|
11,553
|
|
|
19,628
|
|
|||
|
Fully diluted adjusted book value per share numerator
|
$
|
876,362
|
|
|
$
|
836,944
|
|
|
$
|
1,184,779
|
|
|
Basic adjusted and fully diluted adjusted book value per share denominator:
|
|
|
|
|
|
||||||
|
Ordinary shares issued and outstanding for basic adjusted book value per share denominator
|
37,366,327
|
|
|
37,027,467
|
|
|
37,384,543
|
|
|||
|
Add: In-the-money stock options and RSUs issued and outstanding
|
123,320
|
|
|
717,340
|
|
|
1,131,917
|
|
|||
|
Fully diluted adjusted book value per share denominator
|
37,489,647
|
|
|
37,744,807
|
|
|
38,516,460
|
|
|||
|
Basic adjusted book value per share
|
$
|
23.40
|
|
|
$
|
22.29
|
|
|
$
|
31.17
|
|
|
Fully diluted adjusted book value per share
|
23.38
|
|
|
22.17
|
|
|
30.76
|
|
|||
|
|
Year ended December 31
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
($ in thousands)
|
||||||||||
|
Income (loss) before income tax
|
$
|
47,209
|
|
|
$
|
(333,688
|
)
|
|
$
|
112,651
|
|
|
Add (subtract):
|
|
|
|
|
|
||||||
|
Investment (income) loss
|
(76,183
|
)
|
|
281,924
|
|
|
(122,575
|
)
|
|||
|
Other (income) expense
|
935
|
|
|
3,413
|
|
|
(2,987
|
)
|
|||
|
Corporate expenses
|
9,225
|
|
|
8,782
|
|
|
8,003
|
|
|||
|
Amortization of ILW
(1)
|
—
|
|
|
(2,340
|
)
|
|
—
|
|
|||
|
Net underwriting income (loss)
|
$
|
(18,814
|
)
|
|
$
|
(41,909
|
)
|
|
$
|
(4,908
|
)
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Frequency
|
|
$
|
494,292
|
|
|
92.2
|
%
|
|
$
|
464,376
|
|
|
92.5
|
%
|
|
$
|
295,861
|
|
|
91.3
|
%
|
|
Severity
|
|
41,780
|
|
|
7.8
|
|
|
37,748
|
|
|
7.5
|
|
|
28,162
|
|
|
8.7
|
|
|||
|
Total
|
|
$
|
536,072
|
|
|
100.0
|
%
|
|
$
|
502,124
|
|
|
100.0
|
%
|
|
$
|
324,023
|
|
|
100.0
|
%
|
|
Frequency Gross Premiums Written
|
||||
|
Increase (decrease) for the year ended December 31, 2016
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$28.3
|
|
Motor liability and motor physical damage
|
|
Increase primarily due to growth in the volume of underlying policies on existing private passenger motor contracts.
|
|
$27.3
|
|
Specialty -Financial
|
|
Increase primarily relating to in-force unearned premiums assumed at the inception of mortgage insurance contracts bound during 2016. There were no mortgage insurance contracts bound during the comparative period in 2015.
|
|
$12.8
|
|
Casualty -Workers’ Compensation
|
|
Increase primarily due to new contracts written during 2016 and late 2015.
|
|
$(27.7)
|
|
Casualty -Professional
|
|
Decrease partially due to lawyers’ indemnity contracts that were either terminated during the period or not renewed, and partially due to a casualty professional liability contract renewed at a smaller share than the expiring contract written during 2015.
|
|
$(7.8)
|
|
Property - Personal
|
|
Decrease primarily as a net result of the expiring Florida homeowners’ property quota share contracts that we terminated on a cut-off basis, and the unearned portion of the premiums written which was reversed and returned to the ceding insurer. The decrease in personal lines premiums written was partially offset by a new homeowners’ property contract entered into during 2016 that included in-force unearned premiums assumed at the inception of the contract.
|
|
Severity Gross Premiums Written
|
||||
|
Increase (decrease) for the year ended December 31, 2016
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$3.7
|
|
Casualty
|
|
New quota share severity contract written during the second half of 2015 and renewed in 2016, resulting in a full year’s premiums being recorded during 2016 compared to only half year’s premiums recorded during 2015.
|
|
$2.5
|
|
Property
|
|
The comparative 2015 severity premiums written included negative premiums of $2.5 million relating to premiums returned on an excess of loss catastrophe contract. No such return premiums were booked during 2016.
|
|
$1.4
|
|
Multi-line
|
|
The increase due to additional premiums received on a prior excess of loss contract that reported a full limit loss. During 2016, the ceding insurer for this contract reported its final settlement of losses arising from the U.S. sub-prime crisis, which resulted in the loss exceeding the insurer’s retention and triggering additional premiums as per the contract.
|
|
$(3.3)
|
|
Multi-line
|
|
Decrease in premiums relating to catastrophe excess of loss contracts not renewed during 2016.
|
|
Frequency Gross Premiums Written
|
||||
|
Increase (decrease) for the year ended December 31, 2015
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$86.3
|
|
Motor liability and motor physical damage
|
|
Increase primarily due to new private passenger motor contracts written during 2015 as well as growth in the volume of underlying policies on existing private passenger motor contracts.
|
|
$41.3
|
|
Casualty -Professional
|
|
Increase due to new quota share casualty contracts bound during 2015 and during the second half of 2014
|
|
$13.5
|
|
Casualty - General liability
|
|
New quota share contracts written during 2015 and in the latter half of 2014.
|
|
$12.9
|
|
Specialty - Health
|
|
New quota share contracts written during 2015 and in the latter half of 2014.
|
|
$11.9
|
|
Casualty -Workers’ Compensation
|
|
New quota share contracts written during 2015 and in the latter half of 2014.
|
|
$7.5
|
|
Property - Commercial
|
|
New quota share contracts written during 2015 and in the latter half of 2014.
|
|
$(11.6)
|
|
Property - Personal
|
|
Decrease primarily a result of a Florida homeowners’ contract which expired during 2015 and was not renewed.
|
|
$6.7
|
|
Other
|
|
Other insignificant movements.
|
|
Severity Gross Premiums Written
|
||||
|
Increase (decrease) for the year ended December 31, 2015
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$14.7
|
|
Casualty and Property
|
|
New severity quota share contracts written during 2015.
|
|
$7.6
|
|
Multi-line
|
|
Increase due to a multi-year severity quota share contract written during the second half of 2014. As a result, 2015 severity premiums included a full year’s premiums compared to only half year in the comparable period.
|
|
$(10.1)
|
|
Property
|
|
Decrease in premiums relating to catastrophe excess of loss contracts not renewed during 2015.
|
|
$(2.5)
|
|
Property
|
|
Negative premiums relating to premiums returned on an excess of loss catastrophe contract. This contract was previously expected to incur a loss and we had recorded a loss reserve which had triggered an additional premium. During the year ended December 31, 2015, we were informed that losses incurred by the cedent on this contract would not breach into our layer and as a result the additional premium was reversed along with the loss reserve, and a corresponding profit commission expense was recorded during 2015.
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Frequency
|
|
$
|
485,777
|
|
|
92.3
|
%
|
|
$
|
455,375
|
|
|
92.3
|
%
|
|
$
|
286,121
|
|
|
92.1
|
%
|
|
Severity
|
|
40,280
|
|
|
7.7
|
|
|
37,748
|
|
|
7.7
|
|
|
24,409
|
|
|
7.9
|
|
|||
|
Total
|
|
$
|
526,057
|
|
|
100.0
|
%
|
|
$
|
493,123
|
|
|
100.0
|
%
|
|
$
|
310,530
|
|
|
100.0
|
%
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Frequency
|
|
$
|
473,702
|
|
|
92.3
|
%
|
|
$
|
380,565
|
|
|
93.2
|
%
|
|
$
|
330,617
|
|
|
93.3
|
%
|
|
Severity
|
|
39,416
|
|
|
7.7
|
|
|
27,822
|
|
|
6.8
|
|
|
23,623
|
|
|
6.7
|
|
|||
|
Total
|
|
$
|
513,118
|
|
|
100.0
|
%
|
|
$
|
408,387
|
|
|
100.0
|
%
|
|
$
|
354,240
|
|
|
100.0
|
%
|
|
Frequency Premiums Earned
|
||||
|
Increase (decrease) for the year ended December 31, 2016
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$55.7
|
|
Motor liability and motor physical damage
|
|
Increase primarily due to growth in the volume of underlying policies on existing private passenger motor contracts.
|
|
$8.9
|
|
Specialty -Financial
|
|
Increase primarily relating to in-force unearned premiums assumed at the inception of mortgage insurance contracts bound during 2016. There were no mortgage insurance contracts bound during the comparative period in 2015.
|
|
$15.6
|
|
Casualty -Workers’ Compensation
|
|
Increase primarily due to new contracts bound and to a lesser extent due to an increase in the underlying premiums on existing contracts.
|
|
$12.7
|
|
Casualty - General Liability
|
|
Increase in general liability premiums earned primarily due to an increase in the underlying premiums on a casualty contract and, to a lesser extent, due to new contracts written during the second half of 2015 and renewed in 2016.
|
|
$(16.0)
|
|
Property - Personal
|
|
Decrease primarily as a net result of the expiring Florida homeowners’ property quota share contracts that we terminated on a cut-off basis during 2016. The decrease in personal lines premiums written was partially offset by new homeowners’ property quota share contracts entered into during fourth quarter of 2016.
|
|
$16.2
|
|
Other
|
|
Other insignificant increases in commercial property, professional liability and specialty health lines.
|
|
Severity Premiums Earned
|
||||
|
Increase (decrease) for the year ended December 31, 2016
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$5.3
|
|
Casualty
|
|
Increase related to a new quota share severity contract written during the second half of 2015 and renewed in 2016.
|
|
$4.3
|
|
Property
|
|
Increase due to premiums earned on existing severity quota share contracts written during 2015 and renewed in 2016.
|
|
$2.5
|
|
Property
|
|
The comparative 2015 severity premiums written included negative premiums of $2.5 million relating to premiums returned on an excess of loss catastrophe contract. No comparable return premiums were booked during 2016.
|
|
$1.4
|
|
Multi-line
|
|
Increase due to additional premiums received on a prior excess of loss contract that reported a full limit loss. During 2016, the ceding insurer for this contract reported its final settlement of losses arising from the U.S. sub-prime crisis, which resulted in the loss exceeding the insurer’s retention and triggering additional premiums as per the contract.
|
|
$(3.3)
|
|
Multi-line
|
|
Decrease in premiums relating to catastrophe excess of loss contracts not renewed during 2016.
|
|
Frequency Premiums Earned
|
||||
|
Increase (decrease) for the year ended December 31, 2015
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$41.0
|
|
Motor liability and motor physical damage
|
|
Increase primarily due to growth in the volume of underlying policies on existing private passenger motor contracts.
|
|
$29.7
|
|
Casualty -Professional
|
|
Increase due to new quota share casualty contracts bound during 2015 and during the second half of 2014.
|
|
$11.1
|
|
Casualty - General Liability
|
|
Increase in general liability premiums earned primarily due to new contracts written during 2015 and in the second half of 2014.
|
|
$7.9
|
|
Specialty - Health
|
|
Increase as a result of two new employers’ medical stop-loss contracts bound during 2015 and in the second half of 2014, partially offset by lower volume of premiums on existing employers’ medical stop-loss contracts.
|
|
$4.5
|
|
Casualty -Workers’ Compensation
|
|
Increase primarily due to new contracts bound and to a lesser extent due to an increase in the underlying premiums on existing contracts.
|
|
$(11.3)
|
|
Casualty - Professional
|
|
Decrease relating to solicitors’ professional indemnity business due to a lower volume of underlying business written by the cedents.
|
|
$(40.7)
|
|
Property - Personal
|
|
Decrease in personal property premiums partly due to a Florida homeowners’ contract not renewed upon expiration during 2015, and partly due to a lower share on other Florida homeowners’ contracts in effect during the current period compared to the same period in 2014.
|
|
$7.7
|
|
Other
|
|
Increases in commercial property, financial and other specialty lines.
|
|
Severity Premiums Earned
|
||||
|
Increase (decrease) for the year ended December 31, 2015
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$12.5
|
|
Multi-line
|
|
Increase related to new quota share property and casualty severity contracts written during 2015 and the second half of 2014.
|
|
$3.8
|
|
Multi-line
|
|
Severity premiums earned for the year ended December 31, 2015 appear higher than the comparable period in 2014 because the 2014 earned premiums were net of $3.8 million expense relating to a retroceded contract for catastrophic risk protection. This retrocession contract was not renewed in 2015, and instead we purchased an ILW contract which, in accordance with U.S. GAAP, was recorded as a weather derivative swap and the cost of the ILW was recorded in the consolidated statements of income as “other income (expense), net”. For the year ended December 31, 2015, the ILW amortization expense was $2.3 million.
|
|
$(2.5)
|
|
Property
|
|
Negative premiums relating to premiums returned on an excess of loss catastrophe contract. See explanation under “Severity Gross Premiums Written” table above.
|
|
$(10.2)
|
|
Multi-line
|
|
Decrease in premiums relating to severity contracts not renewed or renewed with a smaller share during 2015.
|
|
$0.6
|
|
Other
|
|
Other insignificant movements.
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Frequency
|
|
$
|
358,988
|
|
|
94.3
|
%
|
|
$
|
314,459
|
|
|
99.2
|
%
|
|
$
|
231,185
|
|
|
98.4
|
%
|
|
Severity
|
|
21,827
|
|
|
5.7
|
|
|
2,638
|
|
|
0.8
|
|
|
3,801
|
|
|
1.6
|
|
|||
|
Total
|
|
$
|
380,815
|
|
|
100.0
|
%
|
|
$
|
317,097
|
|
|
100.0
|
%
|
|
$
|
234,986
|
|
|
100.0
|
%
|
|
|
|
Year ended December 31
|
|||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||
|
Frequency
|
|
75.8
|
%
|
|
82.6
|
%
|
|
69.9
|
%
|
|
Severity
|
|
55.4
|
%
|
|
9.5
|
%
|
|
16.1
|
%
|
|
Total
|
|
74.2
|
%
|
|
77.6
|
%
|
|
66.3
|
%
|
|
Notable Frequency Loss Ratio Changes
|
||
|
December 31, 2016
|
||
|
Line of business
|
|
Explanation
|
|
General Liability
|
|
A decrease in loss ratio as a result of lower adverse loss development on the legacy construction defect liabilities. Excluding the construction defect contracts, the overall loss ratios for our frequency business for the years ended December 31, 2016 and 2015, were 71.5% and 69.1%, respectively.
|
|
Property Personal
|
|
Increase in loss ratio due to adverse loss development on Florida homeowners’ insurance contracts as a result of deterioration of sinkhole claims and an increase in the practice of assignment of benefits by public adjusters and attorneys in Florida.
|
|
Motor - Property and Liability
|
|
Increase in loss ratio relating to private passenger motor contract due to increase in loss adjustment expenses on claims.
|
|
Specialty Health
|
|
Higher loss ratio due to favorable loss development recorded in the comparative period in 2015 on employers’ medical stop-loss contracts.
|
|
Professional
|
|
Decrease in loss ratio due to a higher proportion of professional liability premiums earned during 2016 from casualty contracts which have a lower loss ratio than other professional contracts such as solicitors’ indemnity.
|
|
Notable Severity Loss Ratio Changes
|
||
|
December 31, 2016
|
||
|
Line of business
|
|
Explanation
|
|
Property - Commercial
|
|
Increase in loss ratio due to $4.4 million of reserves relating to 2016 natural catastrophe events - Canadian wildfires and Hurricane Matthew.
|
|
Casualty - General liability and Professional
|
|
Increase in loss ratio due to a prior year excess of loss contract that reported a full limit loss arising from the U.S. sub-prime crisis.
|
|
Property - Commercial
|
|
Higher loss ratio because the comparative year ended December 31, 2015 included the reversal of $5.1 million of loss reserves relating to favorable loss development on an excess of loss contract.
|
|
Notable Frequency Loss Ratio Changes
|
||
|
December 31, 2015
|
||
|
Line of business
|
|
Explanation
|
|
General Liability
|
|
An increase in loss ratio as a result of adverse loss development on the legacy construction defect liabilities discussed above.
|
|
Property Personal
|
|
Increase in loss ratio due to adverse loss development on Florida homeowners’ insurance contracts as a result of sinkhole losses and higher than anticipated water damage claims from rainstorms during 2014.
|
|
Motor - Property and Liability
|
|
Increase in loss ratio relating to private passenger motor contract due to increase in loss adjustment expenses on claims.
|
|
Specialty Health
|
|
Decrease in loss ratio due to favorable loss development on the employers’ medical stop-loss contracts, compared to adverse losses recorded during the comparable period in 2014.
|
|
Professional
|
|
Decrease in loss ratio due to a shift in the mix of business from predominantly solicitors’ indemnity contracts to a more diversified professional liability book of business.
|
|
Notable Severity Loss Ratio Changes
|
||
|
December 31, 2015
|
||
|
Line of business
|
|
Explanation
|
|
Property - Commercial
|
|
Lower ratio due to the elimination of $5.1 million of loss reserves on an excess of loss contract entered into in 2008. Excluding this contract, the severity loss ratio for the year ended December 31, 2015 was 25.4% compared to 16.1% for the same period in 2014.
|
|
Other
|
|
Increase in severity loss ratio due to the change in mix of severity business with a higher proportion of quota share severity contracts in effect during the year ended December 31, 2015 compared to the same period in 2014.
|
|
|
Year ended December 31
|
||||||||||||||||||||||||||||||||||
|
|
|
|
2016
|
|
|
|
|
|
2015
|
|
|
|
|
|
2014
|
|
|
||||||||||||||||||
|
|
Gross
|
|
Ceded
|
|
Net
|
|
Gross
|
|
Ceded
|
|
Net
|
|
Gross
|
|
Ceded
|
|
Net
|
||||||||||||||||||
|
|
($ in thousands)
|
||||||||||||||||||||||||||||||||||
|
Losses paid (recovered)
|
$
|
374,270
|
|
|
$
|
(1,600
|
)
|
|
$
|
372,670
|
|
|
$
|
274,713
|
|
|
$
|
(9,851
|
)
|
|
$
|
264,862
|
|
|
$
|
303,272
|
|
|
$
|
(9,695
|
)
|
|
$
|
293,577
|
|
|
Change in loss and loss adjustment expense reserves
|
7,484
|
|
|
661
|
|
|
8,145
|
|
|
44,080
|
|
|
8,155
|
|
|
52,235
|
|
|
(63,897
|
)
|
|
5,306
|
|
|
(58,591
|
)
|
|||||||||
|
Total
|
$
|
381,754
|
|
|
$
|
(939
|
)
|
|
$
|
380,815
|
|
|
$
|
318,793
|
|
|
$
|
(1,696
|
)
|
|
$
|
317,097
|
|
|
$
|
239,375
|
|
|
$
|
(4,389
|
)
|
|
$
|
234,986
|
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Frequency
|
|
$
|
125,388
|
|
|
93.2
|
%
|
|
$
|
106,411
|
|
|
91.6
|
%
|
|
$
|
103,008
|
|
|
95.7
|
%
|
|
Severity
|
|
9,146
|
|
|
6.8
|
|
|
9,796
|
|
|
8.4
|
|
|
4,657
|
|
|
4.3
|
|
|||
|
Total
|
|
$
|
134,534
|
|
|
100.0
|
%
|
|
$
|
116,207
|
|
|
100.0
|
%
|
|
$
|
107,665
|
|
|
100.0
|
%
|
|
|
|
Year ended December 31
|
|||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||
|
Frequency
|
|
26.5
|
%
|
|
28.0
|
%
|
|
31.2
|
%
|
|
Severity
|
|
23.2
|
%
|
|
35.2
|
%
|
|
19.7
|
%
|
|
Total
|
|
26.2
|
%
|
|
28.5
|
%
|
|
30.4
|
%
|
|
Notable Frequency Acquisition Cost Ratio Changes
|
||
|
December 31, 2016
|
||
|
Line of business
|
|
Explanation
|
|
Motor - Property and Liability
|
|
A decrease in the sliding scale ceding commissions on our private passenger motor contracts which experienced adverse loss development during 2016.
|
|
Professional
|
|
Increase due to a shift in the mix of professional liability business from predominantly solicitors’ indemnity contracts with lower acquisition cost ratios to casualty professional liability business, which has a higher acquisition cost ratio.
|
|
Other
|
|
A decrease due to the change in mix of business. The Florida homeowners’ contracts terminated during 2016 had a higher acquisition cost ratio. Meanwhile a higher proportion of the earned premiums related to the motor business, which has a lower acquisition cost ratio.
|
|
Notable Severity Acquisition Cost Ratio Changes
|
||
|
December 31, 2016
|
||
|
Line of business
|
|
Explanation
|
|
Property - Commercial
|
|
Decrease was due to the 2015 comparative ratio being unusually high due to profit commission of $3.4 million recorded on an excess of loss contract. The profit commission was triggered by the elimination of loss reserves on this contract based on updated information received from the insurer.
|
|
Notable Frequency Acquisition Cost Ratio Changes
|
||
|
December 31, 2015
|
||
|
Line of business
|
|
Explanation
|
|
Motor - Property and Liability
|
|
The private passenger motor contracts in force during 2015 reported lower ceding commissions than the prior year, which also contributed to a lower frequency acquisition cost ratio for the year ended December 31, 2015.
|
|
Property - Personal
|
|
Decrease due to Florida homeowners’ insurance contracts that contain sliding scale ceding commissions, which decreased during the year ended December 31, 2015 as a result of adverse loss development on those contracts.
|
|
Professional
|
|
Decrease was partly offset by a change in mix of professional liability contracts that carry higher ceding commission rates than the predominantly solicitors’ professional indemnity contracts in force during the year ended 2014.
|
|
Notable Severity Acquisition Cost Ratio Changes
|
||
|
December 31, 2015
|
||
|
Line of business
|
|
Explanation
|
|
Property - Commercial
|
|
Increase due to profit commission of $3.4 million recorded on an excess of loss contract during 2015. The profit commission was triggered by the elimination of loss reserves on this contract based on updated information received from the insurer.
|
|
|
Year ended December 31
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
($ in thousands)
|
||||||||||
|
Underwriting expenses
|
$
|
16,583
|
|
|
$
|
14,652
|
|
|
$
|
16,497
|
|
|
Corporate expenses
|
9,225
|
|
|
8,782
|
|
|
8,003
|
|
|||
|
General and administrative expenses
|
$
|
25,808
|
|
|
$
|
23,434
|
|
|
$
|
24,500
|
|
|
|
|
Year ended December 31
|
||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Realized gains (losses)
|
|
$
|
(113,836
|
)
|
|
$
|
22,227
|
|
|
$
|
352,133
|
|
|
Change in unrealized gains and losses
|
|
209,993
|
|
|
(265,401
|
)
|
|
(187,753
|
)
|
|||
|
Investment related foreign exchange gains (losses)
|
|
2,988
|
|
|
(3,725
|
)
|
|
14,797
|
|
|||
|
Interest and dividend income, net of withholding taxes
|
|
23,915
|
|
|
15,313
|
|
|
31,423
|
|
|||
|
Interest, dividend and other expenses
|
|
(22,334
|
)
|
|
(31,092
|
)
|
|
(38,892
|
)
|
|||
|
Investment advisor compensation
|
|
(24,543
|
)
|
|
(19,246
|
)
|
|
(49,133
|
)
|
|||
|
Net investment income (loss)
|
|
$
|
76,183
|
|
|
$
|
(281,924
|
)
|
|
$
|
122,575
|
|
|
|
Year ended December 31
|
|||||||
|
|
2016
|
|
2015
|
|
2014
|
|||
|
Long portfolio gains (losses)
|
18.7
|
%
|
|
(17.2
|
)%
|
|
17.8
|
%
|
|
Short portfolio gains (losses)
|
(11.2
|
)%
|
|
0.4
|
%
|
|
(4.2
|
)%
|
|
Macro gains (losses)
|
2.0
|
%
|
|
(1.9
|
)%
|
|
(1.1
|
)%
|
|
Other income and expenses
1
|
(1.7
|
)%
|
|
(1.5
|
)%
|
|
(1.7
|
)%
|
|
Gross investment return
|
7.8
|
%
|
|
(20.2
|
)%
|
|
10.8
|
%
|
|
Net investment return
|
7.2
|
%
|
|
(20.2
|
)%
|
|
8.7
|
%
|
|
|
Year ended December 31
|
|||||||||||||||||||||||||
|
|
|
|
2016
|
|
|
|
|
|
2015
|
|
|
|
|
|
2014
|
|
|
|||||||||
|
|
Frequency
|
|
Severity
|
|
Total
|
|
Frequency
|
|
Severity
|
|
Total
|
|
Frequency
|
|
Severity
|
|
Total
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Loss ratio
|
75.8
|
%
|
|
55.4
|
%
|
|
74.2
|
%
|
|
82.6
|
%
|
|
9.5
|
%
|
|
77.6
|
%
|
|
69.9
|
%
|
|
16.1
|
%
|
|
66.3
|
%
|
|
Acquisition cost ratio
|
26.5
|
|
|
23.2
|
|
|
26.2
|
|
|
28.0
|
|
|
35.2
|
|
|
28.5
|
|
|
31.2
|
|
|
19.7
|
|
|
30.4
|
|
|
Composite ratio
|
102.3
|
%
|
|
78.6
|
%
|
|
100.4
|
%
|
|
110.6
|
%
|
|
44.7
|
%
|
|
106.1
|
%
|
|
101.1
|
%
|
|
35.8
|
%
|
|
96.7
|
%
|
|
Underwriting expense ratio
|
|
|
|
|
3.2
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
|
4.7
|
|
||||||
|
Combined ratio
|
|
|
|
|
103.6
|
%
|
|
|
|
|
|
110.3
|
%
|
|
|
|
|
|
101.4
|
%
|
||||||
|
Increase (decrease) as of December 31, 2016
($ in millions)
|
|
Line of business
|
|
Explanation
|
|
$39.3
|
|
Commodities - Gold
|
|
Increase primarily due to an increase in physical gold holdings and to a lesser extent due to increases in unrealized gains.
|
|
$63.2
|
|
Financial contracts receivable
|
|
Increase in derivative assets partially due to purchase of additional call options, commodity swaps and total return swaps, and partially due to an increase in unrealized gains relating to the derivatives held as of December 31, 2016.
|
|
$(62.2)
|
|
Equities - Listed
|
|
Decrease primarily due to disposal of equity securities during 2016, partially offset by an increase in unrealized gains due to price appreciation.
|
|
$(18.5)
|
|
Non U.S. Sovereign debt
|
|
Decrease due to non U.S. sovereign debt instruments disposed during 2016.
|
|
•
|
Fluctuations in the share price due to an overall positive investment market;
|
|
•
|
Sudden unexpected changes in the underlying business model of the issuer;
|
|
•
|
Changes in laws and regulations relating to short sales;
|
|
•
|
Press releases and earnings guidance issued by the issuer;
|
|
•
|
A merger or acquisition of the issuer at a price in excess of the current share price;
|
|
•
|
The shares of the issuer becoming difficult to borrow; or
|
|
•
|
A short squeeze.
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
|
|
Case
Reserves |
|
IBNR
|
|
Total
|
|
Case
Reserves |
|
IBNR
|
|
Total
|
||||||||||||
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Frequency
|
$
|
81,676
|
|
|
$
|
183,134
|
|
|
$
|
264,810
|
|
|
$
|
103,347
|
|
|
$
|
165,740
|
|
|
$
|
269,087
|
|
|
Severity
|
17,139
|
|
|
24,692
|
|
|
41,831
|
|
|
8,188
|
|
|
28,722
|
|
|
36,910
|
|
||||||
|
Total
|
$
|
98,815
|
|
|
$
|
207,826
|
|
|
$
|
306,641
|
|
|
$
|
111,535
|
|
|
$
|
194,462
|
|
|
$
|
305,997
|
|
|
|
|
Incurred claims and allocated claim adjustment expenses, net of reinsurance
|
|||||||||||||||||||||||||||||
|
|
|
For the years ended December 31,
|
|||||||||||||||||||||||||||||
|
Underwriting Year
|
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
||||||||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||||||||||||
|
2007
|
|
$
|
9,983
|
|
$
|
35,876
|
|
$
|
53,770
|
|
$
|
52,846
|
|
$
|
52,882
|
|
$
|
52,105
|
|
$
|
56,074
|
|
$
|
56,073
|
|
$
|
56,071
|
|
$
|
60,495
|
|
|
2008
|
|
|
35,728
|
|
86,544
|
|
94,775
|
|
103,100
|
|
106,686
|
|
106,858
|
|
110,078
|
|
110,636
|
|
110,212
|
|
|||||||||||
|
2009
|
|
|
|
57,703
|
|
161,941
|
|
196,953
|
|
213,617
|
|
210,245
|
|
212,881
|
|
218,917
|
|
218,703
|
|
||||||||||||
|
2010
|
|
|
|
|
64,829
|
|
197,412
|
|
244,708
|
|
254,853
|
|
267,328
|
|
296,222
|
|
316,544
|
|
|||||||||||||
|
2011
|
|
|
|
|
|
62,145
|
|
206,404
|
|
334,598
|
|
334,494
|
|
349,348
|
|
349,744
|
|
||||||||||||||
|
2012
|
|
|
|
|
|
|
71,632
|
|
174,404
|
|
191,582
|
|
189,779
|
|
190,610
|
|
|||||||||||||||
|
2013
|
|
|
|
|
|
|
|
174,175
|
|
290,965
|
|
292,908
|
|
293,181
|
|
||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
77,812
|
|
237,136
|
|
264,888
|
|
|||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
102,606
|
|
347,171
|
|
||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
79,050
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
Total
|
$
|
2,230,598
|
|
||||||||||||||||||
|
|
|
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
|
|||||||||||||||||||||||||||||
|
|
|
For the years ended December 31,
|
|||||||||||||||||||||||||||||
|
Underwriting Year
|
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
||||||||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||||||||||||
|
2007
|
|
$
|
573
|
|
$
|
6,007
|
|
$
|
18,917
|
|
$
|
26,680
|
|
$
|
32,033
|
|
$
|
38,097
|
|
$
|
38,279
|
|
$
|
38,284
|
|
$
|
38,285
|
|
$
|
47,285
|
|
|
2008
|
|
|
8,272
|
|
37,187
|
|
72,487
|
|
84,643
|
|
91,799
|
|
95,913
|
|
99,625
|
|
101,513
|
|
108,299
|
|
|||||||||||
|
2009
|
|
|
|
14,214
|
|
83,737
|
|
150,229
|
|
178,071
|
|
190,460
|
|
203,099
|
|
206,435
|
|
217,443
|
|
||||||||||||
|
2010
|
|
|
|
|
18,866
|
|
118,558
|
|
175,577
|
|
205,265
|
|
227,634
|
|
248,179
|
|
314,203
|
|
|||||||||||||
|
2011
|
|
|
|
|
|
20,430
|
|
125,933
|
|
289,323
|
|
316,399
|
|
329,336
|
|
346,893
|
|
||||||||||||||
|
2012
|
|
|
|
|
|
|
19,220
|
|
119,703
|
|
172,623
|
|
181,825
|
|
185,221
|
|
|||||||||||||||
|
2013
|
|
|
|
|
|
|
|
69,940
|
|
215,761
|
|
265,778
|
|
276,761
|
|
||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
26,550
|
|
151,733
|
|
200,419
|
|
|||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
37,898
|
|
216,283
|
|
||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
17,463
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,930,270
|
|
|||||||||||||||||
|
|
|
January 1, 2017
|
||||||
|
Zone
|
|
Maximum Single Event Loss
|
|
Maximum Aggregate Loss
|
||||
|
|
|
($ in thousands)
|
||||||
|
United States, Canada and the Caribbean
|
|
$
|
196,154
|
|
|
$
|
229,881
|
|
|
Europe
|
|
107,357
|
|
|
127,567
|
|
||
|
Japan
|
|
107,357
|
|
|
127,567
|
|
||
|
Rest of the world
|
|
107,357
|
|
|
127,567
|
|
||
|
Maximum Aggregate
|
|
196,154
|
|
|
229,881
|
|
||
|
|
|
January 1, 2017
|
||||||
|
|
|
1-in-250 year return period
|
||||||
|
Zone
|
|
Single Event Loss
|
|
Aggregate Loss
|
||||
|
|
|
($ in thousands)
|
||||||
|
United States, Canada and the Caribbean
|
|
$
|
97,124
|
|
|
$
|
110,376
|
|
|
Europe
|
|
28,197
|
|
|
35,392
|
|
||
|
Japan
|
|
7,761
|
|
|
7,986
|
|
||
|
Rest of the world
|
|
7,741
|
|
|
7,838
|
|
||
|
Maximum
|
|
97,124
|
|
|
112,401
|
|
||
|
|
Less than
1 year |
|
1-3 years
|
|
3-5 years
|
|
More than
5 years |
|
Total
|
||||||||||
|
|
($ in thousands)
|
||||||||||||||||||
|
Operating lease obligations
(1)
|
$
|
621
|
|
|
$
|
543
|
|
|
$
|
213
|
|
|
$
|
—
|
|
|
$
|
1,377
|
|
|
Private equity and limited partnerships
(2)
|
9,210
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,210
|
|
|||||
|
Loss and loss adjustment expense reserves
(3)
|
144,542
|
|
|
84,148
|
|
|
34,216
|
|
|
43,735
|
|
|
306,641
|
|
|||||
|
|
$
|
154,373
|
|
|
$
|
84,691
|
|
|
$
|
34,429
|
|
|
$
|
43,735
|
|
|
$
|
317,228
|
|
|
•
|
|
equity price risk;
|
|
•
|
|
commodity price risk;
|
|
•
|
|
foreign currency risk;
|
|
•
|
|
interest rate risk;
|
|
•
|
|
credit risk; and
|
|
•
|
|
political risk.
|
|
|
10% increase in commodity prices
|
|
10% decrease in commodity prices
|
||||||||||
|
Commodity
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
||||||
|
|
($ in thousands)
|
|
|
|
($ in thousands)
|
|
|
||||||
|
Gold
|
$
|
13,730
|
|
|
1.2
|
%
|
|
$
|
(13,730
|
)
|
|
(1.2
|
)%
|
|
Natural Gas
|
6,731
|
|
|
0.6
|
|
|
(6,731
|
)
|
|
(0.6
|
)
|
||
|
Oil
|
2,820
|
|
|
0.2
|
|
|
(2,820
|
)
|
|
(0.2
|
)
|
||
|
Total
|
$
|
23,281
|
|
|
2.0
|
%
|
|
$
|
(23,281
|
)
|
|
(2.0
|
)%
|
|
|
10% increase in U.S. dollar
|
|
10% decrease in U.S. dollar
|
||||||||||
|
Foreign Currency
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
||||||
|
|
($ in thousands)
|
||||||||||||
|
Australian Dollar
|
296
|
|
|
—
|
|
|
(296
|
)
|
|
—
|
|
||
|
British Pound
|
(641
|
)
|
|
(0.1
|
)
|
|
641
|
|
|
0.1
|
|
||
|
Chinese Yuan
|
7,137
|
|
|
0.6
|
|
|
(3,491
|
)
|
|
(0.3
|
)
|
||
|
Japanese Yen
|
2,190
|
|
|
0.2
|
|
|
(2,034
|
)
|
|
(0.2
|
)
|
||
|
South Korean Won
|
(613
|
)
|
|
(0.1
|
)
|
|
613
|
|
|
0.1
|
|
||
|
Other
|
(329
|
)
|
|
—
|
|
|
329
|
|
|
—
|
|
||
|
Total
|
$
|
8,040
|
|
|
0.6
|
%
|
|
$
|
(4,238
|
)
|
|
(0.3
|
)%
|
|
|
100 basis point increase
in interest rates |
|
100 basis point decrease
in interest rates |
||||||||||
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
||||||
|
|
($ in thousands)
|
||||||||||||
|
Debt instruments
|
$
|
15,806
|
|
|
1.4
|
%
|
|
$
|
(20,635
|
)
|
|
(1.8
|
)%
|
|
Interest rate swaps
|
4,001
|
|
|
0.3
|
|
|
(4,001
|
)
|
|
(0.3
|
)
|
||
|
Net exposure to interest rate risk
|
$
|
19,807
|
|
|
1.7
|
%
|
|
$
|
(24,636
|
)
|
|
(2.1
|
)%
|
|
|
●
|
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
|
|
|
|
|
|
|
●
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
|
|
|
|
|
|
|
●
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on its financial statements.
|
|
|
|
Page
|
|
|
|
(a)(1)
|
Financial Statements
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
Consolidated Balance Sheets as of December 31, 2016 and 2015
|
|
|
|
|
|
Consolidated Statements of Income for the years ended December 31, 2016, 2015 and 2014
|
|
|
|
|
|
Consolidated Statements of Shareholders' Equity for the years ended December 31, 2016, 2015 and 2014
|
|
|
|
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2016, 2015 and 2014
|
|
|
|
|
|
Notes to the Consolidated Financial Statements
|
|
|
|
|
(a)(2)
|
Financial Statement Schedules
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
(a)(3)
|
The exhibits required to be filed by this Item 15. are set forth in the
Exhibit Index
accompanying this report.
|
|
|
|
|
|
|
|
|
|
|
|
GREENLIGHT CAPITAL RE, LTD.
|
|
By:
|
/s/ Barton Hedges
|
|
|
Barton Hedges
Chief Executive Officer |
|
|
February 22, 2017
|
|
|
/s/ DAVID M. EINHORN
|
|
/s/ LEONARD GOLDBERG
|
|
|
David M. Einhorn
Director |
|
Leonard Goldberg
Director |
|
|
February 22, 2017
|
|
February 22, 2017
|
|
|
|
|
|
|
|
/s/ FRANK D. LACKNER
|
|
/s/ ALAN BROOKS
|
|
|
Frank D. Lackner
Director |
|
Alan Brooks
Director |
|
|
February 22, 2017
|
|
February 22, 2017
|
|
|
|
|
|
|
|
/s/ IAN ISAACS
|
|
/s/ JOSEPH P. PLATT
|
|
|
Ian Isaacs
Director |
|
Joseph P. Platt
Director |
|
|
February 22, 2017
|
|
February 22, 2017
|
|
|
|
|
|
|
|
/s/ TIM COURTIS
|
|
/s/ BRYAN MURPHY
|
|
|
Tim Courtis
Chief Financial Officer (principal financial and accounting officer) |
|
Bryan Murphy
Director |
|
|
February 22, 2017
|
|
February 22, 2017
|
|
|
|
|
|
|
|
/s/ BARTON HEDGES
|
|
|
|
|
Barton Hedges
Director & Chief Executive Officer (principal executive officer) |
|
|
|
|
February 22, 2017
|
|
|
|
|
2016
|
|
2015
|
||||
|
Assets
|
|
|
|
||||
|
Investments
|
|
|
|
||||
|
Debt instruments, trading, at fair value
|
$
|
22,473
|
|
|
$
|
39,087
|
|
|
Equity securities, trading, at fair value
|
844,001
|
|
|
905,994
|
|
||
|
Other investments, at fair value
|
156,063
|
|
|
119,083
|
|
||
|
Total investments
|
1,022,537
|
|
|
1,064,164
|
|
||
|
Cash and cash equivalents
|
39,858
|
|
|
112,162
|
|
||
|
Restricted cash and cash equivalents
|
1,202,651
|
|
|
1,236,589
|
|
||
|
Financial contracts receivable, at fair value
|
76,381
|
|
|
13,215
|
|
||
|
Reinsurance balances receivable
|
219,126
|
|
|
187,940
|
|
||
|
Loss and loss adjustment expenses recoverable
|
2,704
|
|
|
3,368
|
|
||
|
Deferred acquisition costs, net
|
61,022
|
|
|
59,823
|
|
||
|
Unearned premiums ceded
|
2,377
|
|
|
3,251
|
|
||
|
Notes receivable, net
|
33,734
|
|
|
25,146
|
|
||
|
Other assets
|
4,303
|
|
|
6,864
|
|
||
|
Total assets
|
$
|
2,664,693
|
|
|
$
|
2,712,522
|
|
|
Liabilities and equity
|
|
|
|
||||
|
Liabilities
|
|
|
|
||||
|
Securities sold, not yet purchased, at fair value
|
$
|
859,902
|
|
|
$
|
882,906
|
|
|
Financial contracts payable, at fair value
|
2,237
|
|
|
28,245
|
|
||
|
Due to prime brokers
|
319,830
|
|
|
396,453
|
|
||
|
Loss and loss adjustment expense reserves
|
306,641
|
|
|
305,997
|
|
||
|
Unearned premium reserves
|
222,527
|
|
|
211,954
|
|
||
|
Reinsurance balances payable
|
41,415
|
|
|
18,326
|
|
||
|
Funds withheld
|
5,927
|
|
|
7,143
|
|
||
|
Other liabilities
|
14,527
|
|
|
12,725
|
|
||
|
Total liabilities
|
1,773,006
|
|
|
1,863,749
|
|
||
|
Equity
|
|
|
|
||||
|
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)
|
—
|
|
|
—
|
|
||
|
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 31,111,432 (2015: 30,772,572): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,895 (2015: 6,254,895))
|
3,737
|
|
|
3,703
|
|
||
|
Additional paid-in capital
|
500,337
|
|
|
496,401
|
|
||
|
Retained earnings
|
370,168
|
|
|
325,287
|
|
||
|
Shareholders’ equity attributable to shareholders
|
874,242
|
|
|
825,391
|
|
||
|
Non-controlling interest in joint venture
|
17,445
|
|
|
23,382
|
|
||
|
Total equity
|
891,687
|
|
|
848,773
|
|
||
|
Total liabilities and equity
|
$
|
2,664,693
|
|
|
$
|
2,712,522
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
Revenues
|
|
|
|
|
|
||||||
|
Gross premiums written
|
$
|
536,072
|
|
|
$
|
502,124
|
|
|
$
|
324,023
|
|
|
Gross premiums ceded
|
(10,015
|
)
|
|
(9,001
|
)
|
|
(13,493
|
)
|
|||
|
Net premiums written
|
526,057
|
|
|
493,123
|
|
|
310,530
|
|
|||
|
Change in net unearned premium reserves
|
(12,939
|
)
|
|
(84,736
|
)
|
|
43,710
|
|
|||
|
Net premiums earned
|
513,118
|
|
|
408,387
|
|
|
354,240
|
|
|||
|
Net investment income (loss)
|
76,183
|
|
|
(281,924
|
)
|
|
122,575
|
|
|||
|
Other income (expense), net
|
(935
|
)
|
|
(3,413
|
)
|
|
2,987
|
|
|||
|
Total revenues
|
588,366
|
|
|
123,050
|
|
|
479,802
|
|
|||
|
Expenses
|
|
|
|
|
|
||||||
|
Loss and loss adjustment expenses incurred, net
|
380,815
|
|
|
317,097
|
|
|
234,986
|
|
|||
|
Acquisition costs, net
|
134,534
|
|
|
116,207
|
|
|
107,665
|
|
|||
|
General and administrative expenses
|
25,808
|
|
|
23,434
|
|
|
24,500
|
|
|||
|
Total expenses
|
541,157
|
|
|
456,738
|
|
|
367,151
|
|
|||
|
Income (loss) before income tax
|
47,209
|
|
|
(333,688
|
)
|
|
112,651
|
|
|||
|
Income tax (expense) benefit
|
(509
|
)
|
|
1,755
|
|
|
624
|
|
|||
|
Net income (loss) including non-controlling interest
|
46,700
|
|
|
(331,933
|
)
|
|
113,275
|
|
|||
|
Loss (income) attributable to non-controlling interest in joint venture
|
(1,819
|
)
|
|
5,508
|
|
|
(3,683
|
)
|
|||
|
Net income (loss)
|
$
|
44,881
|
|
|
$
|
(326,425
|
)
|
|
$
|
109,592
|
|
|
Earnings (loss) per share
|
|
|
|
|
|
||||||
|
Basic
|
$
|
1.20
|
|
|
$
|
(8.90
|
)
|
|
$
|
2.94
|
|
|
Diluted
|
$
|
1.20
|
|
|
$
|
(8.90
|
)
|
|
$
|
2.89
|
|
|
Weighted average number of ordinary shares used in the determination of earnings and loss per share
|
|
|
|
|
|
||||||
|
Basic
|
37,267,145
|
|
|
36,670,466
|
|
|
37,242,687
|
|
|||
|
Diluted
|
37,340,018
|
|
|
36,670,466
|
|
|
37,874,387
|
|
|||
|
|
Ordinary share capital
|
|
Additional paid-in capital
|
|
Retained earnings
|
|
Shareholders' equity attributable to shareholders
|
|
Non-controlling
interest in joint venture |
|
Total equity
|
||||||||||||
|
Balance at December 31, 2013
|
$
|
3,705
|
|
|
$
|
496,622
|
|
|
$
|
551,268
|
|
|
$
|
1,051,595
|
|
|
$
|
34,709
|
|
|
$
|
1,086,304
|
|
|
Issue of Class A ordinary shares, net of forfeitures
|
33
|
|
|
—
|
|
|
—
|
|
|
33
|
|
|
—
|
|
|
33
|
|
||||||
|
Share-based compensation expense, net of forfeitures
|
—
|
|
|
3,931
|
|
|
—
|
|
|
3,931
|
|
|
—
|
|
|
3,931
|
|
||||||
|
Non-controlling interest contribution into (withdrawal from) joint venture, net
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,502
|
)
|
|
(9,502
|
)
|
||||||
|
Income (loss) attributable to non-controlling interest in joint venture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,683
|
|
|
3,683
|
|
||||||
|
Net income (loss)
|
—
|
|
|
—
|
|
|
109,592
|
|
|
109,592
|
|
|
—
|
|
|
109,592
|
|
||||||
|
Balance at December 31, 2014
|
$
|
3,738
|
|
|
$
|
500,553
|
|
|
$
|
660,860
|
|
|
$
|
1,165,151
|
|
|
$
|
28,890
|
|
|
$
|
1,194,041
|
|
|
Issue of Class A ordinary shares, net of forfeitures
|
26
|
|
|
—
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
26
|
|
||||||
|
Repurchase of Class A ordinary shares
|
(61
|
)
|
|
(8,483
|
)
|
|
(9,148
|
)
|
|
(17,692
|
)
|
|
—
|
|
|
(17,692
|
)
|
||||||
|
Share-based compensation expense, net of forfeitures
|
—
|
|
|
4,248
|
|
|
—
|
|
|
4,248
|
|
|
—
|
|
|
4,248
|
|
||||||
|
Short-swing sale profit from shareholder
|
—
|
|
|
83
|
|
|
—
|
|
|
83
|
|
|
—
|
|
|
83
|
|
||||||
|
Income (loss) attributable to non-controlling interest in joint venture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,508
|
)
|
|
(5,508
|
)
|
||||||
|
Net income (loss)
|
—
|
|
|
—
|
|
|
(326,425
|
)
|
|
(326,425
|
)
|
|
—
|
|
|
(326,425
|
)
|
||||||
|
Balance at December 31, 2015
|
$
|
3,703
|
|
|
$
|
496,401
|
|
|
$
|
325,287
|
|
|
$
|
825,391
|
|
|
$
|
23,382
|
|
|
$
|
848,773
|
|
|
Issue of Class A ordinary shares, net of forfeitures
|
34
|
|
|
—
|
|
|
—
|
|
|
34
|
|
|
—
|
|
|
34
|
|
||||||
|
Share-based compensation expense, net of forfeitures
|
—
|
|
|
3,936
|
|
|
—
|
|
|
3,936
|
|
|
—
|
|
|
3,936
|
|
||||||
|
Non-controlling interest contribution into (withdrawal from) joint venture, net
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,756
|
)
|
|
(7,756
|
)
|
||||||
|
Income (loss) attributable to non-controlling interest in joint venture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,819
|
|
|
1,819
|
|
||||||
|
Net income (loss)
|
—
|
|
|
—
|
|
|
44,881
|
|
|
44,881
|
|
|
—
|
|
|
44,881
|
|
||||||
|
Balance at December 31, 2016
|
$
|
3,737
|
|
|
$
|
500,337
|
|
|
$
|
370,168
|
|
|
$
|
874,242
|
|
|
$
|
17,445
|
|
|
$
|
891,687
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
Cash provided by (used in) operating activities
|
|
|
|
|
|
||||||
|
Net income (loss)
|
$
|
44,881
|
|
|
$
|
(326,425
|
)
|
|
$
|
109,592
|
|
|
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
|
|
|
|
|
|
||||||
|
Net change in unrealized gains and losses on investments and financial contracts
|
(209,993
|
)
|
|
265,401
|
|
|
187,753
|
|
|||
|
Net realized gains (losses) on investments and financial contracts
|
113,836
|
|
|
(22,227
|
)
|
|
(352,133
|
)
|
|||
|
Foreign exchange (gains) losses on cash and investments
|
3,094
|
|
|
6,225
|
|
|
(14,797
|
)
|
|||
|
Income (loss) attributable to non-controlling interest in joint venture
|
1,819
|
|
|
(5,508
|
)
|
|
3,683
|
|
|||
|
Share-based compensation expense, net of forfeitures
|
3,970
|
|
|
4,274
|
|
|
3,964
|
|
|||
|
Depreciation expense
|
390
|
|
|
405
|
|
|
436
|
|
|||
|
Net change in
|
|
|
|
|
|
||||||
|
Reinsurance balances receivable
|
(31,186
|
)
|
|
(83,113
|
)
|
|
16,155
|
|
|||
|
Loss and loss adjustment expenses recoverable
|
664
|
|
|
(916
|
)
|
|
5,306
|
|
|||
|
Deferred acquisition costs, net
|
(1,199
|
)
|
|
(25,403
|
)
|
|
17,377
|
|
|||
|
Unearned premiums ceded
|
874
|
|
|
776
|
|
|
(854
|
)
|
|||
|
Other assets
|
2,171
|
|
|
(1,791
|
)
|
|
(1,349
|
)
|
|||
|
Loss and loss adjustment expense reserves
|
644
|
|
|
41,754
|
|
|
(65,651
|
)
|
|||
|
Unearned premium reserves
|
10,573
|
|
|
83,218
|
|
|
(44,321
|
)
|
|||
|
Reinsurance balances payable
|
23,089
|
|
|
7,524
|
|
|
1,583
|
|
|||
|
Funds withheld
|
(1,216
|
)
|
|
585
|
|
|
(3,568
|
)
|
|||
|
Other liabilities
|
1,802
|
|
|
(2,224
|
)
|
|
3,092
|
|
|||
|
Net cash provided by (used in) operating activities
|
(35,787
|
)
|
|
(57,445
|
)
|
|
(133,732
|
)
|
|||
|
Investing activities
|
|
|
|
|
|
||||||
|
Purchases of investments, trading
|
(1,310,837
|
)
|
|
(1,252,969
|
)
|
|
(1,603,856
|
)
|
|||
|
Sales of investments, trading
|
1,470,118
|
|
|
1,388,162
|
|
|
1,722,936
|
|
|||
|
Payments for financial contracts
|
(60,414
|
)
|
|
(25,765
|
)
|
|
(13,302
|
)
|
|||
|
Proceeds from financial contracts
|
20,426
|
|
|
7,002
|
|
|
113,011
|
|
|||
|
Securities sold, not yet purchased
|
699,237
|
|
|
892,085
|
|
|
934,769
|
|
|||
|
Dispositions of securities sold, not yet purchased
|
(792,970
|
)
|
|
(1,068,891
|
)
|
|
(952,843
|
)
|
|||
|
Change in due to prime brokers
|
(76,623
|
)
|
|
185,383
|
|
|
(103,632
|
)
|
|||
|
Change in restricted cash and cash equivalents, net
|
36,972
|
|
|
50,400
|
|
|
35,476
|
|
|||
|
Change in notes receivable, net
|
(8,588
|
)
|
|
2,279
|
|
|
18,983
|
|
|||
|
Non-controlling interest withdrawal from joint venture, net
|
(7,756
|
)
|
|
—
|
|
|
(9,502
|
)
|
|||
|
Net cash provided by (used in) investing activities
|
(30,435
|
)
|
|
177,686
|
|
|
142,040
|
|
|||
|
Financing activities
|
|
|
|
|
|
||||||
|
Short-swing sale profit from shareholder
|
—
|
|
|
83
|
|
|
—
|
|
|||
|
Repurchase of Class A ordinary shares
|
—
|
|
|
(17,692
|
)
|
|
—
|
|
|||
|
Net cash provided by (used in) financing activities
|
—
|
|
|
(17,609
|
)
|
|
—
|
|
|||
|
Effect of foreign exchange rate changes on cash and cash equivalents
|
(6,082
|
)
|
|
(2,500
|
)
|
|
—
|
|
|||
|
Net increase (decrease) in cash and cash equivalents
|
(72,304
|
)
|
|
100,132
|
|
|
8,308
|
|
|||
|
Cash and cash equivalents at beginning of the period
|
112,162
|
|
|
12,030
|
|
|
3,722
|
|
|||
|
Cash and cash equivalents at end of the period
|
$
|
39,858
|
|
|
$
|
112,162
|
|
|
$
|
12,030
|
|
|
Supplementary information
|
|
|
|
|
|
||||||
|
Interest paid in cash
|
$
|
7,823
|
|
|
$
|
21,959
|
|
|
$
|
21,482
|
|
|
Income tax paid in cash
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Non-cash transfer to notes receivable
|
—
|
|
|
25,859
|
|
|
—
|
|
|||
|
|
Cost
|
|
Accumulated depreciation
|
|
Net book value
|
||||||
|
|
($ in thousands)
|
||||||||||
|
Computer software
|
$
|
556
|
|
|
$
|
(420
|
)
|
|
$
|
136
|
|
|
Furniture and fixtures
|
620
|
|
|
(569
|
)
|
|
51
|
|
|||
|
Leasehold improvements
|
2,002
|
|
|
(1,491
|
)
|
|
511
|
|
|||
|
Total
|
$
|
3,178
|
|
|
$
|
(2,480
|
)
|
|
$
|
698
|
|
|
|
Cost
|
|
Accumulated depreciation
|
|
Net book value
|
||||||
|
|
($ in thousands)
|
||||||||||
|
Computer software
|
$
|
556
|
|
|
$
|
(348
|
)
|
|
$
|
208
|
|
|
Furniture and fixtures
|
620
|
|
|
(513
|
)
|
|
107
|
|
|||
|
Leasehold improvements
|
2,002
|
|
|
(1,229
|
)
|
|
773
|
|
|||
|
Total
|
$
|
3,178
|
|
|
$
|
(2,090
|
)
|
|
$
|
1,088
|
|
|
|
Year ended December 31
|
|||||||
|
|
2016
|
|
2015
|
|
2014
|
|||
|
Weighted average shares outstanding - basic
|
37,267,145
|
|
|
36,670,466
|
|
|
37,242,687
|
|
|
Effect of dilutive service provider share-based awards
|
—
|
|
|
—
|
|
|
8,498
|
|
|
Effect of dilutive employee and director share-based awards
|
72,873
|
|
|
—
|
|
|
623,202
|
|
|
Weighted average shares outstanding - diluted
|
37,340,018
|
|
|
36,670,466
|
|
|
37,874,387
|
|
|
Anti-dilutive stock options outstanding
|
435,991
|
|
|
211,821
|
|
|
—
|
|
|
Participating securities excluded from calculation of loss per share
|
—
|
|
|
307,013
|
|
|
—
|
|
|
|
|
Fair value measurements as of December 31, 2016
|
||||||||||||||
|
Description
|
|
Quoted prices in
active markets (Level 1) |
|
Significant other
observable inputs (Level 2) |
|
Significant
unobservable inputs (Level 3) |
|
Total
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Debt instruments
|
|
$
|
—
|
|
|
$
|
21,819
|
|
|
$
|
654
|
|
|
$
|
22,473
|
|
|
Listed equity securities
|
|
823,421
|
|
|
20,580
|
|
|
—
|
|
|
844,001
|
|
||||
|
Commodities
|
|
137,296
|
|
|
—
|
|
|
—
|
|
|
137,296
|
|
||||
|
Private and unlisted equity securities
|
|
—
|
|
|
—
|
|
|
6,109
|
|
|
6,109
|
|
||||
|
|
|
$
|
960,717
|
|
|
$
|
42,399
|
|
|
$
|
6,763
|
|
|
$
|
1,009,879
|
|
|
Private equity funds measured at net asset value
(1)
|
|
|
|
|
|
|
|
12,658
|
|
|||||||
|
Total investments
|
|
|
|
|
|
|
|
$
|
1,022,537
|
|
||||||
|
Financial contracts receivable
|
|
$
|
20
|
|
|
$
|
76,361
|
|
|
$
|
—
|
|
|
$
|
76,381
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Listed equity securities, sold not yet purchased
|
|
$
|
(770,267
|
)
|
|
$
|
—
|
|
|
—
|
|
|
$
|
(770,267
|
)
|
|
|
Debt instruments, sold not yet purchased
|
|
—
|
|
|
(89,635
|
)
|
|
—
|
|
|
(89,635
|
)
|
||||
|
Total securities sold, not yet purchased
|
|
$
|
(770,267
|
)
|
|
$
|
(89,635
|
)
|
|
—
|
|
|
$
|
(859,902
|
)
|
|
|
Financial contracts payable
|
|
$
|
—
|
|
|
$
|
(2,237
|
)
|
|
—
|
|
|
$
|
(2,237
|
)
|
|
|
|
|
Fair value measurements as of December 31, 2015
|
||||||||||||||
|
Description
|
|
Quoted prices in
active markets (Level 1) |
|
Significant other
observable inputs (Level 2) |
|
Significant
unobservable inputs (Level 3) |
|
Total
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Debt instruments
|
|
$
|
—
|
|
|
$
|
38,582
|
|
|
$
|
505
|
|
|
$
|
39,087
|
|
|
Listed equity securities
|
|
900,369
|
|
|
5,625
|
|
|
—
|
|
|
905,994
|
|
||||
|
Commodities
|
|
98,046
|
|
|
—
|
|
|
—
|
|
|
98,046
|
|
||||
|
Private and unlisted equity securities
|
|
—
|
|
|
—
|
|
|
8,452
|
|
|
8,452
|
|
||||
|
|
|
$
|
998,415
|
|
|
$
|
44,207
|
|
|
$
|
8,957
|
|
|
$
|
1,051,579
|
|
|
Private equity funds measured at net asset value
(1)
|
|
|
|
|
|
|
|
12,585
|
|
|||||||
|
Total investments
|
|
|
|
|
|
|
|
$
|
1,064,164
|
|
||||||
|
Financial contracts receivable
|
|
$
|
20
|
|
|
$
|
13,195
|
|
|
$
|
—
|
|
|
$
|
13,215
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Listed equity securities, sold not yet purchased
|
|
$
|
(808,481
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(808,481
|
)
|
|
Debt instruments, sold not yet purchased
|
|
—
|
|
|
(74,425
|
)
|
|
—
|
|
|
(74,425
|
)
|
||||
|
Total securities sold, not yet purchased
|
|
$
|
(808,481
|
)
|
|
$
|
(74,425
|
)
|
|
$
|
—
|
|
|
$
|
(882,906
|
)
|
|
Financial contracts payable
|
|
$
|
(488
|
)
|
|
$
|
(27,757
|
)
|
|
$
|
—
|
|
|
$
|
(28,245
|
)
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||||
|
|
|
Year ended December 31, 2016
|
||||||||||
|
|
|
Assets
|
||||||||||
|
|
|
Debt instruments
|
|
Private and unlisted equity securities
|
|
Total
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Beginning balance
|
|
$
|
505
|
|
|
$
|
8,452
|
|
|
$
|
8,957
|
|
|
Purchases
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Sales
|
|
—
|
|
|
(2,539
|
)
|
|
(2,539
|
)
|
|||
|
Total realized and unrealized gains (losses) and amortization included in earnings, net
|
|
149
|
|
|
196
|
|
|
345
|
|
|||
|
Transfers into Level 3
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Transfers out of Level 3
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Ending balance
|
|
$
|
654
|
|
|
$
|
6,109
|
|
|
$
|
6,763
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||||||||||||||||
|
|
|
Year ended December 31, 2015
|
||||||||||||||||||||||
|
|
|
Assets
|
|
Liabilities
|
||||||||||||||||||||
|
|
|
Debt instruments
|
|
Private and unlisted equity securities
(1)
|
|
Financial contracts receivable
|
|
Listed equity securities
|
|
Total
|
|
Financial contracts payable
|
||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Beginning balance
|
|
$
|
22,259
|
|
|
$
|
6,449
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
28,708
|
|
|
$
|
—
|
|
|
Purchases
|
|
—
|
|
|
1,769
|
|
|
2,340
|
|
|
—
|
|
|
4,109
|
|
|
—
|
|
||||||
|
Sales
|
|
(21,561
|
)
|
|
(41
|
)
|
|
—
|
|
|
—
|
|
|
(21,602
|
)
|
|
—
|
|
||||||
|
Total realized and unrealized gains (losses) and amortization included in earnings, net
|
|
(193
|
)
|
|
275
|
|
|
(3,027
|
)
|
|
(692
|
)
|
|
(3,637
|
)
|
|
314
|
|
||||||
|
Transfers into Level 3
|
|
—
|
|
|
—
|
|
|
2,536
|
|
|
5,189
|
|
|
7,725
|
|
|
8,835
|
|
||||||
|
Transfers out of Level 3
|
|
—
|
|
|
—
|
|
|
(1,849
|
)
|
|
(4,497
|
)
|
|
(6,346
|
)
|
|
(9,149
|
)
|
||||||
|
Ending balance
|
|
$
|
505
|
|
|
$
|
8,452
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,957
|
|
|
$
|
—
|
|
|
|
|
Cost/
amortized
cost
|
|
Unrealized
gains
|
|
Unrealized
losses
|
|
Fair
value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Corporate debt – U.S.
|
|
$
|
21,294
|
|
|
$
|
6,509
|
|
|
$
|
(5,331
|
)
|
|
$
|
22,472
|
|
|
Corporate debt – Non U.S.
|
|
2,109
|
|
|
—
|
|
|
(2,108
|
)
|
|
1
|
|
||||
|
Total debt instruments
|
|
$
|
23,403
|
|
|
$
|
6,509
|
|
|
$
|
(7,439
|
)
|
|
$
|
22,473
|
|
|
|
|
Cost/
amortized
cost
|
|
Unrealized
gains
|
|
Unrealized
losses
|
|
Fair
value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Corporate debt – U.S.
|
|
$
|
25,674
|
|
|
$
|
155
|
|
|
$
|
(5,519
|
)
|
|
$
|
20,310
|
|
|
Corporate debt – Non U.S.
|
|
2,109
|
|
|
—
|
|
|
(1,795
|
)
|
|
314
|
|
||||
|
Sovereign debt – Non U.S.
|
|
17,688
|
|
|
1,225
|
|
|
(450
|
)
|
|
18,463
|
|
||||
|
Total debt instruments
|
|
$
|
45,471
|
|
|
$
|
1,380
|
|
|
$
|
(7,764
|
)
|
|
$
|
39,087
|
|
|
|
|
2016
|
|
2015
|
||||||||||||
|
|
|
Cost/
amortized
cost
|
|
Fair
value
|
|
Cost/
amortized
cost
|
|
Fair
value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Within one year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
From one to five years
|
|
17,803
|
|
|
19,492
|
|
|
4,202
|
|
|
4,129
|
|
||||
|
From five to ten years
|
|
4,649
|
|
|
2,327
|
|
|
18,840
|
|
|
14,780
|
|
||||
|
More than ten years
|
|
951
|
|
|
654
|
|
|
22,429
|
|
|
20,178
|
|
||||
|
|
|
$
|
23,403
|
|
|
$
|
22,473
|
|
|
$
|
45,471
|
|
|
$
|
39,087
|
|
|
|
|
Cost
|
|
Unrealized
gains
|
|
Unrealized
losses
|
|
Fair
value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
753,813
|
|
|
$
|
115,379
|
|
|
$
|
(40,706
|
)
|
|
$
|
828,486
|
|
|
Exchange traded funds
|
|
15,056
|
|
|
459
|
|
|
—
|
|
|
15,515
|
|
||||
|
Total equity securities
|
|
$
|
768,869
|
|
|
$
|
115,838
|
|
|
$
|
(40,706
|
)
|
|
$
|
844,001
|
|
|
|
|
Cost
|
|
Unrealized
gains
|
|
Unrealized
losses
|
|
Fair
value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
1,011,424
|
|
|
$
|
67,114
|
|
|
$
|
(187,885
|
)
|
|
$
|
890,653
|
|
|
Exchange traded funds
|
|
31,570
|
|
|
—
|
|
|
(16,229
|
)
|
|
15,341
|
|
||||
|
Total equity securities
|
|
$
|
1,042,994
|
|
|
$
|
67,114
|
|
|
$
|
(204,114
|
)
|
|
$
|
905,994
|
|
|
|
|
Cost
|
|
Unrealized
gains |
|
Unrealized
losses |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Commodities
|
|
$
|
130,671
|
|
|
$
|
6,625
|
|
|
$
|
—
|
|
|
$
|
137,296
|
|
|
Private and unlisted equity securities
|
|
14,418
|
|
|
4,375
|
|
|
(26
|
)
|
|
18,767
|
|
||||
|
|
|
$
|
145,089
|
|
|
$
|
11,000
|
|
|
$
|
(26
|
)
|
|
$
|
156,063
|
|
|
|
|
Cost
|
|
Unrealized
gains |
|
Unrealized
losses |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Commodities
|
|
$
|
102,092
|
|
|
$
|
—
|
|
|
$
|
(4,046
|
)
|
|
$
|
98,046
|
|
|
Private and unlisted equity securities
|
|
18,720
|
|
|
3,491
|
|
|
(1,174
|
)
|
|
21,037
|
|
||||
|
|
|
$
|
120,812
|
|
|
$
|
3,491
|
|
|
$
|
(5,220
|
)
|
|
$
|
119,083
|
|
|
|
|
Proceeds
|
|
Unrealized gains
|
|
Unrealized losses
|
|
Fair value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
(690,270
|
)
|
|
$
|
30,768
|
|
|
$
|
(110,765
|
)
|
|
$
|
(770,267
|
)
|
|
Sovereign debt – Non U.S.
|
|
(96,230
|
)
|
|
6,595
|
|
|
—
|
|
|
(89,635
|
)
|
||||
|
|
|
$
|
(786,500
|
)
|
|
$
|
37,363
|
|
|
$
|
(110,765
|
)
|
|
$
|
(859,902
|
)
|
|
|
|
Proceeds
|
|
Unrealized gains
|
|
Unrealized losses
|
|
Fair value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
(803,842
|
)
|
|
$
|
102,469
|
|
|
$
|
(94,681
|
)
|
|
$
|
(796,054
|
)
|
|
Exchange traded funds
|
|
(9,572
|
)
|
|
—
|
|
|
(2,855
|
)
|
|
(12,427
|
)
|
||||
|
Sovereign debt – Non U.S.
|
|
(77,443
|
)
|
|
3,018
|
|
|
—
|
|
|
(74,425
|
)
|
||||
|
|
|
$
|
(890,857
|
)
|
|
$
|
105,487
|
|
|
$
|
(97,536
|
)
|
|
$
|
(882,906
|
)
|
|
Financial Contracts
|
|
Listing
currency (1) |
|
Notional amount of
underlying instruments |
|
Fair value of net assets
(obligations) on financial contracts |
|||
|
|
|
|
|
($ in thousands)
|
|||||
|
Financial contracts receivable
|
|
|
|
|
|
|
|||
|
Call options
|
|
USD
|
|
134,495
|
|
|
$
|
26,508
|
|
|
Commodity Swaps
|
|
USD
|
|
82,009
|
|
|
13,506
|
|
|
|
Interest rate swaps
|
|
JPY
|
|
20,490
|
|
|
218
|
|
|
|
Put options
(2)
|
|
USD
|
|
115,481
|
|
|
6,703
|
|
|
|
Total return swaps – equities
|
|
EUR/GBP/USD
|
|
100,199
|
|
|
29,413
|
|
|
|
Warrants and rights on listed equities
|
|
EUR/USD
|
|
67
|
|
|
33
|
|
|
|
Total financial contracts receivable, at fair value
|
|
|
|
|
|
$
|
76,381
|
|
|
|
Financial contracts payable
|
|
|
|
|
|
|
|||
|
Forwards
|
|
KRW
|
|
6,880
|
|
|
(118
|
)
|
|
|
Put options
|
|
USD
|
|
815
|
|
|
(172
|
)
|
|
|
Total return swaps – equities
|
|
EUR/GBP/KRW/RON/USD
|
|
31,257
|
|
|
(1,947
|
)
|
|
|
Total financial contracts payable, at fair value
|
|
|
|
|
|
$
|
(2,237
|
)
|
|
|
Financial Contracts
|
|
Listing currency
(1)
|
|
Notional amount of
underlying instruments |
|
Fair value of net assets
(obligations) on financial contracts |
|||
|
|
|
|
|
($ in thousands)
|
|||||
|
Financial contracts receivable
|
|
|
|
|
|
|
|||
|
Call options
(2)
|
|
USD
|
|
47,259
|
|
|
$
|
657
|
|
|
Put options
(3)
|
|
USD
|
|
147,326
|
|
|
8,790
|
|
|
|
Total return swaps – equities
|
|
EUR/GBP/USD
|
|
50,205
|
|
|
3,748
|
|
|
|
Warrants and rights on listed equities
|
|
EUR
|
|
59
|
|
|
20
|
|
|
|
Total financial contracts receivable, at fair value
|
|
|
|
|
|
$
|
13,215
|
|
|
|
Financial contracts payable
|
|
|
|
|
|
|
|||
|
Call options
|
|
USD
|
|
2,601
|
|
|
$
|
(64
|
)
|
|
Commodity Swaps
|
|
USD
|
|
42,160
|
|
|
(12,784
|
)
|
|
|
Forwards
|
|
KRW
|
|
2,908
|
|
|
(22
|
)
|
|
|
Futures
|
|
USD
|
|
21,195
|
|
|
(488
|
)
|
|
|
Total return swaps – equities
|
|
EUR/GBP/HKD/RON/MXN/USD
|
|
71,874
|
|
|
(14,887
|
)
|
|
|
Total financial contracts payable, at fair value
|
|
|
|
|
|
$
|
(28,245
|
)
|
|
|
Derivatives not designated as hedging instruments
|
|
Location of gains and losses on derivatives recognized in income
|
|
Gain (loss) on derivatives recognized in income
|
||||||||||
|
|
|
|
|
Year ended December 31
|
||||||||||
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
($ in thousands)
|
||||||||||
|
Commodity swaps
|
|
Net investment income (loss)
|
|
$
|
10,474
|
|
|
$
|
(12,061
|
)
|
|
$
|
—
|
|
|
Credit default swaps, purchased – corporate debt
|
|
Net investment income (loss)
|
|
—
|
|
|
(156
|
)
|
|
(345
|
)
|
|||
|
Credit default swaps, purchased – sovereign debt
|
|
Net investment income (loss)
|
|
—
|
|
|
(90
|
)
|
|
(298
|
)
|
|||
|
Forwards
|
|
Net investment income (loss)
|
|
(302
|
)
|
|
1,009
|
|
|
(490
|
)
|
|||
|
Futures
|
|
Net investment income (loss)
|
|
376
|
|
|
(952
|
)
|
|
16,721
|
|
|||
|
Interest rate options
|
|
Net investment income (loss)
|
|
—
|
|
|
—
|
|
|
(26
|
)
|
|||
|
Interest rate swaps
|
|
Net investment income (loss)
|
|
218
|
|
|
(706
|
)
|
|
—
|
|
|||
|
Options, warrants, and rights
|
|
Net investment income (loss)
|
|
10,261
|
|
|
(13,955
|
)
|
|
1,020
|
|
|||
|
Total return swaps – equities
|
|
Net investment income (loss)
|
|
28,612
|
|
|
(12,590
|
)
|
|
13,142
|
|
|||
|
Weather derivative swap
|
|
Other income (expense), net
|
|
—
|
|
|
(2,340
|
)
|
|
—
|
|
|||
|
Total
|
|
|
|
$
|
49,639
|
|
|
$
|
(41,841
|
)
|
|
$
|
29,724
|
|
|
|
|
Year ended December 31, 2016
|
||||||
|
Derivatives not designated as hedging instruments (notional amounts)
|
|
Entered
|
|
Exited
|
||||
|
|
|
($ in thousands)
|
||||||
|
Commodity swaps
|
|
$
|
141,534
|
|
|
$
|
100,045
|
|
|
Forwards
|
|
6,880
|
|
|
3,128
|
|
||
|
Futures
|
|
1,966,368
|
|
|
1,988,782
|
|
||
|
Interest rate swaps
|
|
20,490
|
|
|
—
|
|
||
|
Options, warrants and rights
(1)
|
|
462,429
|
|
|
366,285
|
|
||
|
Total return swaps
|
|
86,688
|
|
|
59,810
|
|
||
|
Total
|
|
$
|
2,684,389
|
|
|
$
|
2,518,050
|
|
|
|
|
Year ended December 31, 2015
|
||||||
|
Derivatives not designated as hedging instruments (notional amounts)
|
|
Entered
|
|
Exited
|
||||
|
|
|
($ in thousands)
|
||||||
|
Forwards
|
|
$
|
—
|
|
|
$
|
13,377
|
|
|
Futures
|
|
311,536
|
|
|
294,441
|
|
||
|
Interest rate swaps
|
|
9,139,000
|
|
|
7,213,000
|
|
||
|
Options, warrants and rights
(1)
|
|
661,103
|
|
|
341,702
|
|
||
|
Commodity swaps
|
|
103,358
|
|
|
43,261
|
|
||
|
Total return swaps
|
|
67,844
|
|
|
185,128
|
|
||
|
Weather derivative swap
|
|
12,000
|
|
|
12,000
|
|
||
|
Total
|
|
$
|
10,294,841
|
|
|
$
|
8,102,909
|
|
|
December 31, 2016
|
|
(i)
|
|
(ii)
|
|
(iii) = (i) - (ii)
|
|
(iv) Gross amounts not offset in the balance sheet
|
|
(v) = (iii) + (iv)
|
||||||||||||||
|
Description
|
|
Gross amounts of recognized assets (liabilities)
|
|
Gross amounts offset in the balance sheet
|
|
Net amounts of assets (liabilities) presented in the balance sheet
|
|
Financial instruments available for offset
|
|
Cash collateral (received) pledged
|
|
Net amount of asset (liability)
|
||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Financial contracts receivable
|
|
$
|
76,381
|
|
|
$
|
—
|
|
|
$
|
76,381
|
|
|
$
|
(938
|
)
|
|
$
|
(44,572
|
)
|
|
$
|
30,871
|
|
|
Financial contracts payable
|
|
(2,237
|
)
|
|
—
|
|
|
(2,237
|
)
|
|
938
|
|
|
1,299
|
|
|
—
|
|
||||||
|
December 31, 2015
|
|
(i)
|
|
(ii)
|
|
(iii) = (i) - (ii)
|
|
(iv) Gross amounts not offset in the balance sheet
|
|
(v) = (iii) + (iv)
|
||||||||||||||
|
Description
|
|
Gross amounts of recognized assets (liabilities)
|
|
Gross amounts offset in the balance sheet
|
|
Net amounts of assets (liabilities) presented in the balance sheet
|
|
Financial instruments available for offset
|
|
Cash collateral (received) pledged
|
|
Net amount of asset (liability)
|
||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Financial contracts receivable
|
|
$
|
13,215
|
|
|
$
|
—
|
|
|
$
|
13,215
|
|
|
$
|
(8,937
|
)
|
|
$
|
(2,036
|
)
|
|
$
|
2,242
|
|
|
Financial contracts payable
|
|
(28,245
|
)
|
|
—
|
|
|
(28,245
|
)
|
|
8,937
|
|
|
19,308
|
|
|
—
|
|
||||||
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||
|
|
|
($ in thousands)
|
||||||
|
Cash at banks
|
|
$
|
39,368
|
|
|
$
|
44,133
|
|
|
Cash held with brokers
|
|
490
|
|
|
68,029
|
|
||
|
Total cash and cash equivalents
|
|
$
|
39,858
|
|
|
$
|
112,162
|
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||
|
|
|
($ in thousands)
|
||||||
|
Cash held by prime brokers relating to securities sold, not yet purchased
|
|
$
|
859,901
|
|
|
$
|
882,906
|
|
|
Cash collateral relating to letters of credit issued
|
|
234,348
|
|
|
222,852
|
|
||
|
Cash held as collateral in trust accounts
|
|
86,351
|
|
|
78,584
|
|
||
|
Cash and cash equivalents held by swap counterparties
|
|
22,051
|
|
|
52,247
|
|
||
|
Total restricted cash and cash equivalents
|
|
$
|
1,202,651
|
|
|
$
|
1,236,589
|
|
|
|
●
|
case reserves resulting from claims notified to the Company by its clients;
|
|
|
●
|
incurred but not reported (“IBNR”) losses; and
|
|
|
●
|
estimated loss adjustment expenses.
|
|
|
●
|
Paid Loss Development Method
.
Ultimate losses are estimated by calculating past paid loss development factors and applying them to exposure periods with further expected paid loss development. The paid loss development method assumes that losses are paid in a consistent pattern. It provides an objective test of reported loss projections because paid losses contain no reserve estimates. For many coverages, claim payments are made very slowly and it may take years for claims to be fully reported and settled.
|
|
|
●
|
Reported Loss Development Method.
Ultimate losses are estimated by calculating past reported loss development factors and applying them to exposure periods with further expected reported loss development. Since reported losses include payments and case reserves, changes in both of these amounts are incorporated in this method. This approach provides a larger volume of data to estimate ultimate losses than paid loss methods. Thus, reported loss patterns may be less varied than paid loss patterns, especially for coverage that have historically been paid out over a long period of time but for which claims are reported relatively early and case loss reserve estimates have been established.
|
|
|
●
|
Expected Loss Ratio Method.
Ultimate losses are estimated under the expected loss ratio method, by multiplying earned premiums by an expected loss ratio. Expected loss ratio is selected using industry data, historical company data and actuarial professional judgment. This method is used for lines of business and contracts where there are no historical losses or where past loss experience is not credible.
|
|
|
●
|
Bornhuetter-Ferguson Paid Loss Method.
Ultimate losses are estimated by modifying expected loss ratios to the extent paid losses experienced to date differ from what would have been expected to have been paid based upon the selected paid loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of paid losses to calculate ultimate losses. Generally this method is used for lines of business and contracts where there are limited historical paid losses.
|
|
|
●
|
Bornhuetter-Ferguson Reported Loss Method.
Ultimate losses are estimated by modifying expected loss ratios to the extent reported losses experienced to date differ from what would have been expected to have been reported based upon the selected reported loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of reported losses to calculate ultimate losses. Generally this method is used for lines of business and contracts where there are limited historical reported losses.
|
|
|
●
|
Frequency / Severity Method.
Ultimate losses are estimated under this method by multiplying the ultimate number of claims (i.e. the frequency), by the estimated ultimate average cost per claim (i.e. the severity). By analyzing claims experience by its frequency and severity components, the Company is able to examine trends and patterns in the rates of claims emergence (i.e. reporting) and settlement (i.e. closure) as well as in the average cost of claims. The approach is valuable because sometimes there is more inherent stability in the frequency and severity data when viewed separately rather than in the total losses.
|
|
|
|
2016
|
|
2015
|
||||
|
|
|
($ in thousands)
|
||||||
|
Case reserves
|
|
$
|
98,815
|
|
|
$
|
111,535
|
|
|
IBNR
|
|
207,826
|
|
|
194,462
|
|
||
|
Total
|
|
$
|
306,641
|
|
|
$
|
305,997
|
|
|
Consolidated
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Gross balance at January 1
|
|
$
|
305,997
|
|
|
$
|
264,243
|
|
|
$
|
329,894
|
|
|
Less: Losses recoverable
|
|
(3,368
|
)
|
|
(11,523
|
)
|
|
(16,829
|
)
|
|||
|
Net balance at January 1
|
|
302,629
|
|
|
252,720
|
|
|
313,065
|
|
|||
|
Incurred losses related to:
|
|
|
|
|
|
|
||||||
|
Current year
|
|
345,303
|
|
|
266,796
|
|
|
216,757
|
|
|||
|
Prior years
|
|
35,512
|
|
|
50,301
|
|
|
18,229
|
|
|||
|
Total incurred
|
|
380,815
|
|
|
317,097
|
|
|
234,986
|
|
|||
|
Paid losses related to:
|
|
|
|
|
|
|
||||||
|
Current year
|
|
(156,181
|
)
|
|
(132,017
|
)
|
|
(163,139
|
)
|
|||
|
Prior years
|
|
(216,489
|
)
|
|
(132,846
|
)
|
|
(130,438
|
)
|
|||
|
Total paid
|
|
(372,670
|
)
|
|
(264,863
|
)
|
|
(293,577
|
)
|
|||
|
Foreign currency revaluation
|
|
(6,837
|
)
|
|
(2,325
|
)
|
|
(1,754
|
)
|
|||
|
Net balance at December 31
|
|
303,937
|
|
|
302,629
|
|
|
252,720
|
|
|||
|
Add: Losses recoverable
|
|
2,704
|
|
|
3,368
|
|
|
11,523
|
|
|||
|
Gross balance at December 31
|
|
$
|
306,641
|
|
|
$
|
305,997
|
|
|
$
|
264,243
|
|
|
Health
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Gross balance at January 1
|
|
$
|
21,533
|
|
|
$
|
14,137
|
|
|
$
|
9,778
|
|
|
Less: Losses recoverable
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Net balance at January 1
|
|
21,533
|
|
|
14,137
|
|
|
9,778
|
|
|||
|
Incurred losses related to:
|
|
|
|
|
|
|
||||||
|
Current year
|
|
38,726
|
|
|
34,136
|
|
|
32,970
|
|
|||
|
Prior years
|
|
(1,477
|
)
|
|
(2,680
|
)
|
|
2,873
|
|
|||
|
Total incurred
|
|
37,249
|
|
|
31,456
|
|
|
35,843
|
|
|||
|
Paid losses related to:
|
|
|
|
|
|
|
||||||
|
Current year
|
|
(22,039
|
)
|
|
(14,090
|
)
|
|
(19,028
|
)
|
|||
|
Prior years
|
|
(17,750
|
)
|
|
(9,970
|
)
|
|
(12,456
|
)
|
|||
|
Total paid
|
|
(39,789
|
)
|
|
(24,060
|
)
|
|
(31,484
|
)
|
|||
|
Foreign currency revaluation
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Net balance at December 31
|
|
18,993
|
|
|
21,533
|
|
|
14,137
|
|
|||
|
Add: Losses recoverable
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Gross balance at December 31
|
|
$
|
18,993
|
|
|
$
|
21,533
|
|
|
$
|
14,137
|
|
|
●
|
$19.0 million
of losses resulting from the loss portfolio transfer and subsequent novation of the legacy construction defect liabilities;
|
|
●
|
$7.0 million
of adverse loss development relating to our Florida homeowners’ insurance contracts as a result of deterioration of sinkhole claims and an increase in the practice of “assignment of benefits” whereby homeowners assign their rights for filing and settling claims to attorneys and public adjusters. However, because some of these contracts included sliding scale ceding commission rates, the increase in loss reserves was partially offset by a
$1.4 million
decrease in ceding commissions and profit commissions recorded as acquisition costs;
|
|
●
|
$6.7 million
of adverse loss development relating to our private passenger motor contracts. While the loss indications are close to our expectations, the volume and frequency of unmerited suits served to the cedent by attorneys and medical clinics has resulted in an increase in loss adjustment expenses to defend such claims. The increase in loss reserve was partially offset by a
$3.9 million
decrease in ceding commissions recorded as acquisition costs; and
|
|
●
|
$4.5 million
of adverse loss development on an excess of loss contract relating to losses resulting from the U.S. sub-prime crisis. However, because this contract included a provision for additional premiums, the increase in losses was partially offset by
$1.4 million
of additional premiums earned.
|
|
●
|
$36.9 million
of adverse loss development relating to a general liability contract originally written from 2008 to 2011. This contract contains underlying construction defect liability coverage predominantly on single family homes. During the third quarter of 2015, we completed an in-depth analysis, with the assistance of a third party expert, of the construction defect claims reported and the potential for claims not yet reported on this contract. Based on this assessment, we revised the actuarial methodology used for reserving the construction defect claims on this contract, which resulted in an increase in incurred but not reported losses;
|
|
●
|
$14.7 million
of adverse loss development relating to a general liability contract originally written in 2010. This contract contains underlying construction defect liability coverage. Based on updated data received from the insured, we conducted additional actuarial analysis and updated our actuarial input parameters based on consultation with external industry experts. As a result, the average estimated cost per claim was increased;
|
|
●
|
$9.3 million
of adverse loss development relating to our Florida homeowners’ insurance contracts as a result of deterioration of sinkhole losses and higher than anticipated water damage claims from rainstorms and increase in the practice of assignment of benefits. However, because some of these contracts included sliding scale ceding commission rates, the increase in loss reserves was partially offset by a
$5.1 million
decrease in ceding commissions and profit commissions recorded as acquisition costs;
|
|
●
|
$2.4 million
of net adverse loss development relating to our solicitors’ professional indemnity contracts as a result of multiple large claims reported during the period and an increase in incurred losses;
|
|
●
|
$5.1 million
of favorable loss development relating to an excess of loss property contract resulting in the elimination of loss reserves based on updated loss information received from the insured during the period indicating that no losses will breach into our layer of coverage. The decrease in loss reserves was more than offset by a reversal of
$2.5 million
of earned premiums and an accrual of
$3.4 million
of profit commission recorded as acquisition costs;
|
|
●
|
$4.5 million
of favorable loss development relating to private passenger motor contracts during the period. The decrease in loss reserves was partially offset by
$3.3 million
of additional ceding commissions recorded as acquisition costs;
|
|
●
|
$2.3 million
of favorable loss development relating to the employer medical stop-loss business as a result of better than expected claims frequency reported by the cedent; and
|
|
●
|
$1.3 million
of loss reserves released upon commutation of a private passenger motor contract during the period. The decrease in loss reserves was partially offset by
$1.1 million
of additional ceding commissions incurred as part of the commutation agreement.
|
|
●
|
$7.8 million
of adverse loss development, relating to a general liability contract currently in run-off. Loss reserves were increased on this contract after a detailed actuarial review of existing claims data received from the client, which reported an increase in the number of open claims. The loss reserves were also increased to take into account the corresponding claims handling fees expected to be incurred to settle the open claims;
|
|
●
|
$7.1 million
of adverse loss development, net of retrocession recoveries, relating to commercial motor claims on a multi-line quota share contract currently in run-off. Loss reserves were increased on this contract after a detailed actuarial review of existing claims data received from the client, which reported significant increases in incurred losses on some claims as well as an increase in the number of open claims;
|
|
●
|
$4.0 million
of adverse loss development relating to a solicitors’ professional indemnity contract as a result of a combination of large claims reported and increases in case reserves on several smaller claims. Loss reserves were increased on this contract after a detailed review of existing claims data received from the client, audits of claim files at the third party claims administrator and actuarial analysis based on all available information. The contract terms included sliding scale ceding commission rates and profit commissions. As a result, the increase in loss reserves was offset by a
$0.6 million
decrease in ceding commissions and profit commissions which were recorded as decreases to acquisition costs;
|
|
●
|
$3.0 million
of adverse loss development relating to the employer medical stop-loss business. Loss reserves were increased on these contracts after a detailed review of existing claims data received from the clients, audits of claim files at the third party claims administrators and actuarial analysis based on all available information; and
|
|
●
|
$3.8 million
of favorable loss development relating to private passenger automobile business, primarily as a result of better than expected loss development noted on our private passenger automobile contracts after a detailed review of existing claims data received from the clients, audits of claim files and actuarial analysis based on all available information. Since these contracts included sliding scale ceding commission rates, the decrease in loss reserves was offset by a
$2.2 million
increase in ceding commissions recorded as acquisition costs.
|
|
Frequency - Health
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
Incurred claims and allocated claim adjustment expenses, net of reinsurance
|
|
As of December 31, 2016
|
||||||||||||||||||||||||||||||||||||||||
|
|
For the years ended December 31,
|
|
Total IBNR plus expected development on reported claims
|
||||||||||||||||||||||||||||||||||||||||
|
Accident year
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
|||||||||||||||||||||||
|
|
(Unaudited - Supplementary Information)
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
|
($ in thousands)
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2007
|
$
|
107
|
|
|
$
|
97
|
|
|
$
|
107
|
|
|
$
|
105
|
|
|
$
|
105
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
—
|
|
|
2008
|
|
|
10,593
|
|
|
11,677
|
|
|
11,432
|
|
|
11,428
|
|
|
11,249
|
|
|
11,249
|
|
|
11,249
|
|
|
11,247
|
|
|
11,247
|
|
|
—
|
|
||||||||||||
|
2009
|
|
|
|
|
24,905
|
|
|
23,884
|
|
|
23,321
|
|
|
23,327
|
|
|
23,402
|
|
|
23,402
|
|
|
23,401
|
|
|
23,401
|
|
|
—
|
|
|||||||||||||
|
2010
|
|
|
|
|
|
|
36,066
|
|
|
35,916
|
|
|
36,165
|
|
|
36,120
|
|
|
36,120
|
|
|
36,107
|
|
|
36,107
|
|
|
—
|
|
||||||||||||||
|
2011
|
|
|
|
|
|
|
|
|
36,088
|
|
|
36,205
|
|
|
35,755
|
|
|
35,737
|
|
|
35,533
|
|
|
35,533
|
|
|
—
|
|
|||||||||||||||
|
2012
|
|
|
|
|
|
|
|
|
|
|
10,494
|
|
|
9,781
|
|
|
9,723
|
|
|
9,621
|
|
|
9,621
|
|
|
—
|
|
||||||||||||||||
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
43,895
|
|
|
46,844
|
|
|
47,301
|
|
|
47,047
|
|
|
—
|
|
|||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,970
|
|
|
30,154
|
|
|
29,492
|
|
|
—
|
|
||||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,136
|
|
|
33,576
|
|
|
2,307
|
|
|||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,726
|
|
|
16,687
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
264,853
|
|
|
|
||||||||||||||||||||
|
Frequency - Health
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
|
||||||||||||||||||||||||||||||||||||||
|
|
|
For the years ended December 31,
|
||||||||||||||||||||||||||||||||||||||
|
Accident year
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
||||||||||||||||||||
|
|
|
(Unaudited - Supplementary Information)
|
|
|
||||||||||||||||||||||||||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||||||||||||||||||
|
2007
|
|
$
|
—
|
|
|
$
|
40
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
$
|
103
|
|
|
2008
|
|
|
|
4,199
|
|
|
10,890
|
|
|
11,247
|
|
|
11,247
|
|
|
11,247
|
|
|
11,247
|
|
|
11,247
|
|
|
11,247
|
|
|
11,247
|
|
|||||||||||
|
2009
|
|
|
|
|
|
8,617
|
|
|
23,069
|
|
|
23,380
|
|
|
23,401
|
|
|
23,401
|
|
|
23,401
|
|
|
23,401
|
|
|
23,401
|
|
||||||||||||
|
2010
|
|
|
|
|
|
|
|
17,771
|
|
|
35,609
|
|
|
36,107
|
|
|
36,107
|
|
|
36,107
|
|
|
36,107
|
|
|
36,107
|
|
|||||||||||||
|
2011
|
|
|
|
|
|
|
|
|
|
27,104
|
|
|
35,531
|
|
|
35,533
|
|
|
35,533
|
|
|
35,533
|
|
|
35,533
|
|
||||||||||||||
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
9,382
|
|
|
9,621
|
|
|
9,621
|
|
|
9,621
|
|
|
9,621
|
|
|||||||||||||||
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,515
|
|
|
46,971
|
|
|
47,047
|
|
|
47,047
|
|
||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,028
|
|
|
28,921
|
|
|
29,492
|
|
|||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,090
|
|
|
31,269
|
|
||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,039
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
245,859
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
All outstanding liabilities before 2007, net of reinsurance
|
|
|
0
|
|||||||||||||||||||||||||||||
|
|
|
|
|
Liabilities for claims and claims adjustment expenses, net of reinsurance (Health)
|
|
|
$
|
18,993
|
|
|||||||||||||||||||||||||||||||
|
Frequency - Non-Health
|
||||||||||||||||||||||||||||||||||
|
|
Incurred claims and allocated claim adjustment expenses, net of reinsurance
|
|
As of December 31, 2016
|
|||||||||||||||||||||||||||||||
|
|
For the years ended December 31,
|
|
Total IBNR plus expected development on reported claims
|
|||||||||||||||||||||||||||||||
|
Accident year
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
|
|||||||||||||||||||||||
|
|
(Unaudited - Supplementary Information)
|
|
|
|
||||||||||||||||||||||||||||||
|
|
($ in thousands)
|
|
|
|||||||||||||||||||||||||||||||
|
2007
|
$
|
36,425
|
|
$
|
22,631
|
|
$
|
16,527
|
|
$
|
16,232
|
|
$
|
16,232
|
|
$
|
16,237
|
|
$
|
16,237
|
|
$
|
16,237
|
|
$
|
16,237
|
|
$
|
16,235
|
|
|
$
|
—
|
|
|
2008
|
|
38,126
|
|
34,675
|
|
35,893
|
|
38,669
|
|
40,523
|
|
40,161
|
|
41,620
|
|
42,078
|
|
41,707
|
|
|
—
|
|
||||||||||||
|
2009
|
|
|
79,796
|
|
91,523
|
|
101,259
|
|
109,736
|
|
106,040
|
|
107,323
|
|
112,312
|
|
111,741
|
|
|
—
|
|
|||||||||||||
|
2010
|
|
|
|
130,353
|
|
144,230
|
|
162,110
|
|
161,667
|
|
165,525
|
|
173,989
|
|
177,100
|
|
|
95
|
|
||||||||||||||
|
2011
|
|
|
|
|
170,979
|
|
192,356
|
|
203,811
|
|
214,452
|
|
240,618
|
|
256,320
|
|
|
1,922
|
|
|||||||||||||||
|
2012
|
|
|
|
|
|
200,058
|
|
201,019
|
|
201,678
|
|
214,699
|
|
216,590
|
|
|
2,463
|
|
||||||||||||||||
|
2013
|
|
|
|
|
|
|
373,651
|
|
369,772
|
|
370,516
|
|
370,993
|
|
|
7,269
|
|
|||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
176,397
|
|
176,570
|
|
177,499
|
|
|
19,557
|
|
||||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
224,100
|
|
228,027
|
|
|
51,763
|
|
|||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
289,367
|
|
|
156,083
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
Total
|
$
|
1,885,579
|
|
|
|
||||||||||||||||||||
|
Frequency - Non-Health
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
|
||||||||||||||||||||||||||||||||||||||
|
|
|
For the years ended December 31,
|
||||||||||||||||||||||||||||||||||||||
|
Accident year
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
||||||||||||||||||||
|
|
|
(Unaudited - Supplementary Information)
|
|
|
||||||||||||||||||||||||||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||||||||||||||||||
|
2007
|
|
$
|
7,308
|
|
|
$
|
14,425
|
|
|
$
|
16,201
|
|
|
$
|
16,235
|
|
|
$
|
16,235
|
|
|
$
|
16,235
|
|
|
$
|
16,235
|
|
|
$
|
16,235
|
|
|
$
|
16,235
|
|
|
$
|
16,235
|
|
|
2008
|
|
|
|
10,345
|
|
|
25,145
|
|
|
31,683
|
|
|
36,584
|
|
|
39,147
|
|
|
40,265
|
|
|
41,108
|
|
|
41,161
|
|
|
41,707
|
|
|||||||||||
|
2009
|
|
|
|
|
|
26,518
|
|
|
62,220
|
|
|
81,055
|
|
|
94,842
|
|
|
99,832
|
|
|
103,905
|
|
|
105,421
|
|
|
111,741
|
|
||||||||||||
|
2010
|
|
|
|
|
|
|
|
49,616
|
|
|
99,903
|
|
|
128,188
|
|
|
144,517
|
|
|
157,036
|
|
|
162,497
|
|
|
177,006
|
|
|||||||||||||
|
2011
|
|
|
|
|
|
|
|
|
|
78,207
|
|
|
133,960
|
|
|
168,794
|
|
|
185,459
|
|
|
202,694
|
|
|
254,397
|
|
||||||||||||||
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
92,505
|
|
|
175,010
|
|
|
187,570
|
|
|
195,655
|
|
|
214,126
|
|
|||||||||||||||
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
205,227
|
|
|
329,161
|
|
|
355,121
|
|
|
363,724
|
|
||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
82,110
|
|
|
149,253
|
|
|
157,942
|
|
|||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109,087
|
|
|
176,264
|
|
||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133,285
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,646,428
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
All outstanding liabilities before 2007, net of reinsurance
|
|
|
0
|
|||||||||||||||||||||||||||||
|
|
|
|
|
Liabilities for claims and claims adjustment expenses, net of reinsurance (Frequency)
|
|
|
$
|
239,151
|
|
|||||||||||||||||||||||||||||||
|
Severity
|
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Incurred claims and allocated claim adjustment expenses, net of reinsurance
|
|
As of December 31, 2016
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
For the years ended December 31,
|
|
Total IBNR plus expected development on reported claims
|
||||||||||||||||||||||||||||||||||||||||
|
Accident year
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
|||||||||||||||||||||||
|
|
|
(Unaudited - Supplementary Information)
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
|
|
($ in thousands)
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2007
|
|
$
|
6,142
|
|
|
$
|
9,141
|
|
|
$
|
10,266
|
|
|
$
|
8,792
|
|
|
$
|
9,039
|
|
|
$
|
8,634
|
|
|
$
|
10,513
|
|
|
$
|
10,512
|
|
|
$
|
10,513
|
|
|
$
|
12,643
|
|
|
$
|
2,579
|
|
|
2008
|
|
|
|
16,500
|
|
|
19,329
|
|
|
18,237
|
|
|
18,028
|
|
|
17,469
|
|
|
19,583
|
|
|
19,582
|
|
|
17,843
|
|
|
20,212
|
|
|
4,969
|
|
||||||||||||
|
2009
|
|
|
|
|
|
19,055
|
|
|
15,332
|
|
|
14,931
|
|
|
14,290
|
|
|
14,183
|
|
|
14,010
|
|
|
10,820
|
|
|
10,796
|
|
|
6,595
|
|
|||||||||||||
|
2010
|
|
|
|
|
|
|
|
4,492
|
|
|
5,147
|
|
|
14,079
|
|
|
14,042
|
|
|
14,291
|
|
|
14,194
|
|
|
14,332
|
|
|
2,752
|
|
||||||||||||||
|
2011
|
|
|
|
|
|
|
|
|
|
5,071
|
|
|
5,069
|
|
|
5,068
|
|
|
5,079
|
|
|
5,074
|
|
|
5,081
|
|
|
32
|
|
|||||||||||||||
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||||||||||
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,878
|
|
|
1,865
|
|
|
1,494
|
|
|
1,489
|
|
|
10
|
|
|||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,673
|
|
|
4,650
|
|
|
4,708
|
|
|
1,891
|
|
||||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,249
|
|
|
8,387
|
|
|
6,999
|
|
|||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,210
|
|
|
16,353
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
94,857
|
|
|
|
||||||||||||||||||||
|
Severity
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
|
||||||||||||||||||||||||||||||||||||||
|
|
|
For the years ended December 31,
|
||||||||||||||||||||||||||||||||||||||
|
Accident year
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
||||||||||||||||||||
|
|
|
(Unaudited - Supplementary Information)
|
|
|
||||||||||||||||||||||||||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||||||||||||||||||
|
2007
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,765
|
|
|
$
|
3,777
|
|
|
$
|
5,782
|
|
|
$
|
5,802
|
|
|
$
|
5,802
|
|
|
$
|
5,803
|
|
|
$
|
10,064
|
|
|
2008
|
|
|
|
—
|
|
|
—
|
|
|
3,148
|
|
|
6,391
|
|
|
10,320
|
|
|
10,356
|
|
|
10,356
|
|
|
10,504
|
|
|
15,243
|
|
|||||||||||
|
2009
|
|
|
|
|
|
276
|
|
|
2,582
|
|
|
3,364
|
|
|
3,753
|
|
|
3,902
|
|
|
3,959
|
|
|
4,180
|
|
|
4,201
|
|
||||||||||||
|
2010
|
|
|
|
|
|
|
|
281
|
|
|
862
|
|
|
1,112
|
|
|
1,237
|
|
|
5,892
|
|
|
6,061
|
|
|
11,580
|
|
|||||||||||||
|
2011
|
|
|
|
|
|
|
|
|
|
24
|
|
|
5,033
|
|
|
5,038
|
|
|
5,044
|
|
|
5,047
|
|
|
5,048
|
|
||||||||||||||
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94
|
|
|
722
|
|
|
1,214
|
|
|
1,480
|
|
||||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,558
|
|
|
2,498
|
|
|
2,817
|
|
|||||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
418
|
|
|
1,388
|
|
||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
857
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
52,679
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
All outstanding liabilities before 2007, net of reinsurance
|
|
|
0
|
|||||||||||||||||||||||||||||
|
|
|
|
|
Liabilities for claims and claims adjustment expenses, net of reinsurance (Severity)
|
|
|
$
|
42,178
|
|
|||||||||||||||||||||||||||||||
|
|
|
December 31, 2016
|
||
|
|
|
($ in thousands)
|
||
|
Net outstanding liabilities
|
|
|
||
|
Health
|
|
$
|
18,993
|
|
|
Frequency - non-health
|
|
239,151
|
|
|
|
Severity
|
|
42,178
|
|
|
|
Liabilities for claims and claims adjustment expenses, net of reinsurance
|
|
300,322
|
|
|
|
Add: Reinsurance recoverable on unpaid claims
|
|
2,704
|
|
|
|
Add: Unallocated claims adjustment expenses
|
|
3,615
|
|
|
|
Total gross liabilities for unpaid claims and claim adjustment expense
|
|
$
|
306,641
|
|
|
Years
|
|
1
|
|
2
|
|
3
|
|
4
|
|
5
|
|
6
|
|
7
|
|
8
|
|
9
|
|
10
|
||||||||||
|
|
|
(Unaudited - Supplementary Information)
|
||||||||||||||||||||||||||||
|
Frequency - Non-health
|
|
36.6
|
%
|
|
31.5
|
%
|
|
11.2
|
%
|
|
6.1
|
%
|
|
4.8
|
%
|
|
5.4
|
%
|
|
2.4
|
%
|
|
1.5
|
%
|
|
0.4
|
%
|
|
—
|
%
|
|
Severity
|
|
3.1
|
%
|
|
12.4
|
%
|
|
4.3
|
%
|
|
5.9
|
%
|
|
28.5
|
%
|
|
6.3
|
%
|
|
14.7
|
%
|
|
7.5
|
%
|
|
8.3
|
%
|
|
9.1
|
%
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||
|
|
|
Class A
|
|
Class B
|
|
Class A
|
|
Class B
|
|
Class A
|
|
Class B
|
||||||
|
Balance – beginning of year
|
|
30,772,572
|
|
|
6,254,895
|
|
|
31,129,648
|
|
|
6,254,895
|
|
|
30,791,865
|
|
|
6,254,949
|
|
|
Issue of ordinary shares, net of forfeitures
|
|
338,860
|
|
|
—
|
|
|
256,464
|
|
|
—
|
|
|
337,729
|
|
|
—
|
|
|
Repurchase of ordinary shares
|
|
—
|
|
|
—
|
|
|
(613,540
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Class B shares converted to Class A shares
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
54
|
|
|
(54
|
)
|
|
Balance – end of year
|
|
31,111,432
|
|
|
6,254,895
|
|
|
30,772,572
|
|
|
6,254,895
|
|
|
31,129,648
|
|
|
6,254,895
|
|
|
|
|
Number of
non-vested
restricted
shares
|
|
Weighted
average
grant date
fair value
|
|||
|
Balance at December 31, 2014
|
|
330,087
|
|
|
$
|
27.90
|
|
|
Granted
|
|
106,900
|
|
|
31.56
|
|
|
|
Vested
|
|
(120,353
|
)
|
|
26.26
|
|
|
|
Forfeited
|
|
(9,621
|
)
|
|
30.49
|
|
|
|
Balance at December 31, 2015
|
|
307,013
|
|
|
29.74
|
|
|
|
Granted
|
|
192,936
|
|
|
21.53
|
|
|
|
Vested
|
|
(122,620
|
)
|
|
25.66
|
|
|
|
Forfeited
|
|
(11,897
|
)
|
|
29.97
|
|
|
|
Balance at December 31, 2016
|
|
365,432
|
|
|
$
|
26.76
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
|||
|
Risk free rate
|
|
1.54
|
%
|
|
2.15
|
%
|
|
2.47
|
%
|
|
Estimated volatility
|
|
32.4
|
%
|
|
32.8
|
%
|
|
34.3
|
%
|
|
Expected term (in years)
|
|
10
|
|
|
10
|
|
|
10
|
|
|
Dividend yield
|
|
0
|
%
|
|
0
|
%
|
|
0
|
%
|
|
Forfeiture rate
|
|
0
|
%
|
|
0
|
%
|
|
0
|
%
|
|
|
Number of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
grant date
fair value
|
|
Intrinsic value
($ in millions)
|
|
Weighted average remaining contractual term
|
|||||||
|
Balance at December 31, 2013
|
1,402,987
|
|
|
$
|
15.82
|
|
|
$
|
7.08
|
|
|
|
|
|
||
|
Granted
|
31,821
|
|
|
32.37
|
|
|
15.71
|
|
|
|
|
|
||||
|
Exercised
|
(318,500
|
)
|
|
11.29
|
|
|
5.67
|
|
|
$
|
6.7
|
|
|
|
||
|
Balance at December 31, 2014
|
1,116,308
|
|
|
17.58
|
|
|
7.73
|
|
|
$
|
16.8
|
|
|
3.0 years
|
||
|
Granted
|
40,683
|
|
|
26.67
|
|
|
12.29
|
|
|
|
|
|
||||
|
Exercised
|
(250,000
|
)
|
|
11.10
|
|
|
5.57
|
|
|
$
|
4.8
|
|
|
|
||
|
Balance at December 31, 2015
|
906,991
|
|
|
19.78
|
|
|
8.53
|
|
|
$
|
2.6
|
|
|
2.9 years
|
||
|
Granted
|
57,386
|
|
|
19.87
|
|
|
8.71
|
|
|
|
|
|
||||
|
Exercised
|
(421,000
|
)
|
|
12.53
|
|
|
6.44
|
|
|
$
|
3.1
|
|
|
|
||
|
Balance at December 31, 2016
|
543,377
|
|
|
$
|
25.40
|
|
|
$
|
10.17
|
|
|
$
|
0.5
|
|
|
4.7 years
|
|
|
December 31, 2016
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||
|
Number of options exercisable
|
472,042
|
|
|
851,020
|
|
|
1,062,022
|
|
|||
|
Weighted average exercise price
|
$
|
25.73
|
|
|
$
|
19.22
|
|
|
$
|
17.02
|
|
|
Weighted average remaining contractual term
|
4.1
|
|
|
2.6
|
|
|
2.7
|
|
|||
|
Intrinsic value ($ in millions)
|
$
|
0.4
|
|
|
$
|
2.6
|
|
|
$
|
16.6
|
|
|
|
|
Number of
non-vested RSUs |
|
Weighted
average grant date fair value |
|||
|
Balance at December 31, 2014
|
|
15,609
|
|
|
$
|
29.72
|
|
|
Granted
|
|
6,821
|
|
|
32.21
|
|
|
|
Vested
|
|
(260
|
)
|
|
24.30
|
|
|
|
Forfeited
|
|
—
|
|
|
—
|
|
|
|
Balance at December 31, 2015
|
|
22,170
|
|
|
30.55
|
|
|
|
Granted
|
|
7,444
|
|
|
21.56
|
|
|
|
Vested
|
|
(1,799
|
)
|
|
26.48
|
|
|
|
Forfeited
|
|
(11,881
|
)
|
|
29.60
|
|
|
|
Balance at December 31, 2016
|
|
15,934
|
|
|
$
|
27.88
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Realized gains (losses)
|
|
$
|
(113,836
|
)
|
|
$
|
22,227
|
|
|
$
|
352,133
|
|
|
Change in unrealized gains and losses
|
|
209,993
|
|
|
(265,401
|
)
|
|
(187,753
|
)
|
|||
|
Investment related foreign exchange gains (losses)
|
|
2,988
|
|
|
(3,725
|
)
|
|
14,797
|
|
|||
|
Interest and dividend income, net of withholding taxes
|
|
23,915
|
|
|
15,313
|
|
|
31,423
|
|
|||
|
Interest, dividend and other expenses
|
|
(22,334
|
)
|
|
(31,092
|
)
|
|
(38,892
|
)
|
|||
|
Investment advisor compensation
|
|
(24,543
|
)
|
|
(19,246
|
)
|
|
(49,133
|
)
|
|||
|
Net investment income (loss)
|
|
$
|
76,183
|
|
|
$
|
(281,924
|
)
|
|
$
|
122,575
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Current tax (expense) benefit
|
|
$
|
(492
|
)
|
|
$
|
15
|
|
|
$
|
638
|
|
|
Deferred tax (expense) benefit
|
|
(17
|
)
|
|
1,740
|
|
|
(14
|
)
|
|||
|
Income tax (expense) benefit
|
|
$
|
(509
|
)
|
|
$
|
1,755
|
|
|
$
|
624
|
|
|
|
|
Facility
|
|
Termination Date
|
|
Notice period required for termination
|
||
|
|
|
($ in thousands)
|
|
|
|
|
||
|
Butterfield Bank (Cayman) Limited
|
|
100,000
|
|
|
June 30, 2017
|
|
90 days prior to termination date
|
|
|
Citibank Europe plc
|
|
400,000
|
|
|
October 11, 2017
|
|
120 days prior to termination date
|
|
|
JP Morgan Chase Bank N.A.
|
|
100,000
|
|
|
January 27, 2018
|
|
120 days prior to termination date
|
|
|
|
|
$
|
600,000
|
|
|
|
|
|
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
|
Total
|
||||||||||||||
|
|
($ in thousands)
|
||||||||||||||||||||||||||
|
Operating lease obligations
|
$
|
621
|
|
|
$
|
388
|
|
|
$
|
155
|
|
|
$
|
155
|
|
|
$
|
58
|
|
|
$
|
—
|
|
|
$
|
1,377
|
|
|
Private equity and limited partnerships
(1)
|
9,210
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,210
|
|
|||||||
|
|
$
|
9,831
|
|
|
$
|
388
|
|
|
$
|
155
|
|
|
$
|
155
|
|
|
$
|
58
|
|
|
$
|
—
|
|
|
$
|
10,587
|
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Largest broker
|
|
$
|
274,816
|
|
|
51.3
|
%
|
|
$
|
278,003
|
|
|
55.4
|
%
|
|
$
|
161,405
|
|
|
49.8
|
%
|
|
2nd largest broker
|
|
104,684
|
|
|
19.5
|
|
|
110,246
|
|
|
22.0
|
|
|
61,809
|
|
|
19.1
|
|
|||
|
3rd largest broker
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
40,773
|
|
|
12.6
|
|
|||
|
|
|
$
|
379,500
|
|
|
70.8
|
%
|
|
$
|
388,249
|
|
|
77.4
|
%
|
|
$
|
263,987
|
|
|
81.5
|
%
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
Property
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Commercial
|
|
$
|
16,180
|
|
|
3.0
|
%
|
|
$
|
15,633
|
|
|
3.1
|
%
|
|
$
|
11,826
|
|
|
3.6
|
%
|
|
Motor
|
|
39,551
|
|
|
7.4
|
|
|
34,529
|
|
|
6.9
|
|
|
24,008
|
|
|
7.4
|
|
|||
|
Personal
|
|
47,893
|
|
|
8.9
|
|
|
57,495
|
|
|
11.5
|
|
|
63,997
|
|
|
19.8
|
|
|||
|
Total Property
|
|
103,624
|
|
|
19.3
|
|
|
107,657
|
|
|
21.5
|
|
|
99,831
|
|
|
30.8
|
|
|||
|
Casualty
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
General Liability
|
|
34,450
|
|
|
6.4
|
|
|
27,620
|
|
|
5.5
|
|
|
11,234
|
|
|
3.5
|
|
|||
|
Motor
|
|
227,030
|
|
|
42.4
|
|
|
203,624
|
|
|
40.6
|
|
|
127,858
|
|
|
39.4
|
|
|||
|
Professional
|
|
37,847
|
|
|
7.1
|
|
|
65,607
|
|
|
13.1
|
|
|
26,129
|
|
|
8.1
|
|
|||
|
Workers' Compensation
|
|
25,456
|
|
|
4.7
|
|
|
12,646
|
|
|
2.5
|
|
|
730
|
|
|
0.2
|
|
|||
|
Total Casualty
|
|
324,783
|
|
|
60.6
|
|
|
309,497
|
|
|
61.7
|
|
|
165,951
|
|
|
51.2
|
|
|||
|
Specialty
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Accident & Health
|
|
52,114
|
|
|
9.7
|
|
|
56,784
|
|
|
11.3
|
|
|
43,837
|
|
|
13.5
|
|
|||
|
Financial
|
|
34,658
|
|
|
6.5
|
|
|
6,699
|
|
|
1.3
|
|
|
5,067
|
|
|
1.6
|
|
|||
|
Marine
|
|
9,127
|
|
|
1.7
|
|
|
9,283
|
|
|
1.8
|
|
|
5,120
|
|
|
1.6
|
|
|||
|
Other
|
|
11,766
|
|
|
2.2
|
|
|
12,204
|
|
|
2.4
|
|
|
4,217
|
|
|
1.3
|
|
|||
|
Total Specialty
|
|
107,665
|
|
|
20.1
|
|
|
84,970
|
|
|
16.8
|
|
|
58,241
|
|
|
18.0
|
|
|||
|
|
|
$
|
536,072
|
|
|
100.0
|
%
|
|
$
|
502,124
|
|
|
100.0
|
%
|
|
$
|
324,023
|
|
|
100.0
|
%
|
|
*
|
During the year ended December 31, 2016, the Company revised its classification of the lines of business. As a result the gross written premiums in the above table relating to certain lines of business previously reported for the years ended December 31, 2015 and 2014, have been reclassified to confirm to the current period presentation.
|
|
|
|
Year ended December 31
|
|||||||||||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
|
|
|
($ in thousands)
|
|||||||||||||||||||
|
U.S. and Caribbean
|
|
$
|
432,144
|
|
|
80.6
|
%
|
|
$
|
383,236
|
|
|
76.3
|
%
|
|
$
|
275,402
|
|
|
85.0
|
%
|
|
Worldwide
(1)
|
|
97,810
|
|
|
18.2
|
|
|
104,336
|
|
|
20.8
|
|
|
31,106
|
|
|
9.6
|
|
|||
|
Europe
|
|
6,250
|
|
|
1.2
|
|
|
14,085
|
|
|
2.8
|
|
|
17,432
|
|
|
5.4
|
|
|||
|
Asia
(2)
|
|
(132
|
)
|
|
—
|
|
|
467
|
|
|
0.1
|
|
|
83
|
|
|
—
|
|
|||
|
|
|
$
|
536,072
|
|
|
100.0
|
%
|
|
$
|
502,124
|
|
|
100.0
|
%
|
|
$
|
324,023
|
|
|
100.0
|
%
|
|
|
|
2016
|
||||||||||||||
|
|
|
Quarter ended
|
||||||||||||||
|
|
|
March 31 |
|
June 30 |
|
September 30 |
|
December 31 |
||||||||
|
|
|
($ in thousands, except per share amounts)
|
||||||||||||||
|
Revenues
|
|
|
|
|
|
|
|
|
||||||||
|
Gross premiums written
|
|
$
|
166,792
|
|
|
$
|
92,237
|
|
|
$
|
128,205
|
|
|
$
|
148,838
|
|
|
Gross premiums ceded
|
|
(2,107
|
)
|
|
(3,522
|
)
|
|
(2,119
|
)
|
|
(2,267
|
)
|
||||
|
Net premiums written
|
|
164,685
|
|
|
88,715
|
|
|
126,086
|
|
|
146,571
|
|
||||
|
Change in net unearned premium reserves
|
|
(26,573
|
)
|
|
36,867
|
|
|
(13,294
|
)
|
|
(9,939
|
)
|
||||
|
Net premiums earned
|
|
138,112
|
|
|
125,582
|
|
|
112,792
|
|
|
136,632
|
|
||||
|
Net investment income (loss)
|
|
28,435
|
|
|
(38,054
|
)
|
|
32,945
|
|
|
52,857
|
|
||||
|
Other income (expense), net
|
|
(271
|
)
|
|
282
|
|
|
(192
|
)
|
|
(754
|
)
|
||||
|
Total revenues
|
|
166,276
|
|
|
87,810
|
|
|
145,545
|
|
|
188,735
|
|
||||
|
Expenses
|
|
|
|
|
|
|
|
|
||||||||
|
Loss and loss adjustment expenses incurred, net
|
|
90,668
|
|
|
111,376
|
|
|
81,467
|
|
|
97,304
|
|
||||
|
Acquisition costs, net
|
|
38,963
|
|
|
35,484
|
|
|
25,844
|
|
|
34,243
|
|
||||
|
General and administrative expenses
|
|
6,999
|
|
|
4,994
|
|
|
6,937
|
|
|
6,878
|
|
||||
|
Total expenses
|
|
136,630
|
|
|
151,854
|
|
|
114,248
|
|
|
138,425
|
|
||||
|
Income (loss) before income tax expense
|
|
29,646
|
|
|
(64,044
|
)
|
|
31,297
|
|
|
50,310
|
|
||||
|
Income tax (expense) benefit
|
|
(204
|
)
|
|
258
|
|
|
(305
|
)
|
|
(258
|
)
|
||||
|
Net income (loss) including non-controlling interest
|
|
29,442
|
|
|
(63,786
|
)
|
|
30,992
|
|
|
50,052
|
|
||||
|
Loss (income) attributable to non-controlling interest in joint venture
|
|
(773
|
)
|
|
791
|
|
|
(981
|
)
|
|
(856
|
)
|
||||
|
Net income (loss)
|
|
$
|
28,669
|
|
|
$
|
(62,995
|
)
|
|
$
|
30,011
|
|
|
$
|
49,196
|
|
|
Earnings (loss) per share
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
0.77
|
|
|
$
|
(1.69
|
)
|
|
$
|
0.80
|
|
|
$
|
1.32
|
|
|
Diluted
|
|
$
|
0.77
|
|
|
$
|
(1.69
|
)
|
|
$
|
0.80
|
|
|
$
|
1.31
|
|
|
Weighted average number of ordinary shares used in the determination of earnings and loss per share
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
37,107,039
|
|
|
37,281,392
|
|
|
37,323,575
|
|
|
37,381,714
|
|
||||
|
Diluted
|
|
37,422,921
|
|
|
37,281,392
|
|
|
37,385,481
|
|
|
37,414,570
|
|
||||
|
|
|
2015
|
||||||||||||||
|
|
|
Quarter ended
|
||||||||||||||
|
|
|
March 31 |
|
June 30 |
|
September 30 |
|
December 31 |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Revenues
|
|
|
|
|
|
|
|
|
||||||||
|
Gross premiums written
|
|
$
|
129,682
|
|
|
$
|
92,990
|
|
|
$
|
134,568
|
|
|
$
|
144,884
|
|
|
Gross premiums ceded
|
|
(1,626
|
)
|
|
(1,868
|
)
|
|
(2,288
|
)
|
|
(3,219
|
)
|
||||
|
Net premiums written
|
|
128,056
|
|
|
91,122
|
|
|
132,280
|
|
|
141,665
|
|
||||
|
Change in net unearned premium reserves
|
|
(33,263
|
)
|
|
563
|
|
|
(30,286
|
)
|
|
(21,750
|
)
|
||||
|
Net premiums earned
|
|
94,793
|
|
|
91,685
|
|
|
101,994
|
|
|
119,915
|
|
||||
|
Net investment income (loss)
|
|
(24,829
|
)
|
|
(20,305
|
)
|
|
(191,322
|
)
|
|
(45,468
|
)
|
||||
|
Other income (expense), net
|
|
1,588
|
|
|
(3,760
|
)
|
|
(542
|
)
|
|
(699
|
)
|
||||
|
Total revenues
|
|
71,552
|
|
|
67,620
|
|
|
(89,870
|
)
|
|
73,748
|
|
||||
|
Expenses
|
|
|
|
|
|
|
|
|
||||||||
|
Loss and loss adjustment expenses incurred, net
|
|
63,207
|
|
|
76,653
|
|
|
97,421
|
|
|
79,816
|
|
||||
|
Acquisition costs, net
|
|
26,841
|
|
|
23,939
|
|
|
32,146
|
|
|
33,281
|
|
||||
|
General and administrative expenses
|
|
6,160
|
|
|
6,894
|
|
|
5,382
|
|
|
4,998
|
|
||||
|
Total expenses
|
|
96,208
|
|
|
107,486
|
|
|
134,949
|
|
|
118,095
|
|
||||
|
Income (loss) before income tax
|
|
(24,656
|
)
|
|
(39,866
|
)
|
|
(224,819
|
)
|
|
(44,347
|
)
|
||||
|
Income tax (expense) benefit
|
|
215
|
|
|
(54
|
)
|
|
1,233
|
|
|
361
|
|
||||
|
Net income (loss) including non-controlling interest
|
|
(24,441
|
)
|
|
(39,920
|
)
|
|
(223,586
|
)
|
|
(43,986
|
)
|
||||
|
Loss (income) attributable to non-controlling interest in joint venture
|
|
394
|
|
|
324
|
|
|
3,909
|
|
|
881
|
|
||||
|
Net income (loss)
|
|
$
|
(24,047
|
)
|
|
$
|
(39,596
|
)
|
|
$
|
(219,677
|
)
|
|
$
|
(43,105
|
)
|
|
Earnings (loss) per share
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
(0.65
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(5.98
|
)
|
|
$
|
(1.17
|
)
|
|
Diluted
|
|
$
|
(0.65
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(5.98
|
)
|
|
$
|
(1.17
|
)
|
|
Weighted average number of ordinary shares used in the determination of earnings and loss per share
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
37,173,008
|
|
|
37,303,265
|
|
|
36,710,216
|
|
|
36,720,454
|
|
||||
|
Diluted
|
|
37,173,008
|
|
|
37,303,265
|
|
|
36,710,216
|
|
|
36,720,454
|
|
||||
|
Type of Investment
|
|
Cost
|
|
Fair Value
|
|
Balance
Sheet Value |
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Debt instruments, trading, at fair value
|
|
$
|
23,403
|
|
|
$
|
22,473
|
|
|
$
|
22,473
|
|
|
Equity securities, trading, at fair value
|
|
|
|
|
|
|
||||||
|
Equities – listed
|
|
753,813
|
|
|
828,486
|
|
|
828,486
|
|
|||
|
Exchange traded funds
|
|
15,056
|
|
|
15,515
|
|
|
15,515
|
|
|||
|
Total equity securities, trading, at fair value
|
|
768,869
|
|
|
844,001
|
|
|
844,001
|
|
|||
|
Total investments, trading
|
|
$
|
792,272
|
|
|
$
|
866,474
|
|
|
$
|
866,474
|
|
|
Other investments, at fair value
|
|
|
|
|
|
|
||||||
|
Commodities
|
|
$
|
130,671
|
|
|
$
|
137,296
|
|
|
$
|
137,296
|
|
|
Private and unlisted equity securities
|
|
14,418
|
|
|
18,767
|
|
|
18,767
|
|
|||
|
Total other investments, at fair value
|
|
145,089
|
|
|
156,063
|
|
|
156,063
|
|
|||
|
Total investments
|
|
$
|
937,361
|
|
|
$
|
1,022,537
|
|
|
$
|
1,022,537
|
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||
|
|
|
($ in thousands)
|
||||||
|
Assets
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
6
|
|
|
$
|
6
|
|
|
Investment in subsidiaries
|
|
888,095
|
|
|
840,196
|
|
||
|
Notes receivable
|
|
15,164
|
|
|
2,175
|
|
||
|
Total assets
|
|
$
|
903,265
|
|
|
$
|
842,377
|
|
|
Liabilities and equity
|
|
|
|
|
||||
|
Liabilities
|
|
|
|
|
||||
|
Due to subsidiaries
|
|
$
|
29,023
|
|
|
$
|
16,986
|
|
|
Total liabilities
|
|
29,023
|
|
|
16,986
|
|
||
|
Shareholders’ equity
|
|
|
|
|
||||
|
Share capital
|
|
3,737
|
|
|
3,703
|
|
||
|
Additional paid-in capital
|
|
500,337
|
|
|
496,401
|
|
||
|
Retained earnings
|
|
370,168
|
|
|
325,287
|
|
||
|
Total shareholders’ equity
|
|
874,242
|
|
|
825,391
|
|
||
|
Total liabilities and equity
|
|
$
|
903,265
|
|
|
$
|
842,377
|
|
|
|
|
Year ended December 31
|
||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Revenue
|
|
|
|
|
|
|
||||||
|
Investment income
|
|
$
|
952
|
|
|
$
|
5,962
|
|
|
$
|
671
|
|
|
Total revenues
|
|
952
|
|
|
5,962
|
|
|
671
|
|
|||
|
Expenses
|
|
|
|
|
|
|
|
|
|
|||
|
General and administrative expenses
|
|
4,042
|
|
|
4,048
|
|
|
3,806
|
|
|||
|
Net income (loss) before equity in earnings of consolidated subsidiaries
|
|
(3,090
|
)
|
|
1,914
|
|
|
(3,135
|
)
|
|||
|
Equity in earnings of consolidated subsidiaries
|
|
47,971
|
|
|
(328,339
|
)
|
|
112,727
|
|
|||
|
Consolidated net income (loss)
|
|
$
|
44,881
|
|
|
$
|
(326,425
|
)
|
|
$
|
109,592
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Cash provided by (used in) operating activities
|
|
|
|
|
|
|
||||||
|
Net income (loss)
|
|
$
|
44,881
|
|
|
$
|
(326,425
|
)
|
|
$
|
109,592
|
|
|
Adjustments to reconcile net income (loss) to cash provided by operating activities
|
|
|
|
|
|
|
||||||
|
Equity in earnings of consolidated subsidiaries
|
|
(47,971
|
)
|
|
328,339
|
|
|
(112,727
|
)
|
|||
|
Share-based compensation expense
|
|
4,042
|
|
|
4,048
|
|
|
3,806
|
|
|||
|
Net change in
|
|
|
|
|
|
|
||||||
|
Due from subsidiaries
|
|
—
|
|
|
15,276
|
|
|
971
|
|
|||
|
Due to subsidiaries
|
|
12,037
|
|
|
16,986
|
|
|
(3,808
|
)
|
|||
|
Net cash (used in) provided by operating activities
|
|
12,989
|
|
|
38,450
|
|
|
(2,008
|
)
|
|||
|
Investing activities
|
|
|
|
|
|
|
||||||
|
Change in note receivable
|
|
(12,989
|
)
|
|
(609
|
)
|
|
2,162
|
|
|||
|
Contributed surplus to subsidiaries, net
|
|
—
|
|
|
(20,000
|
)
|
|
—
|
|
|||
|
Net cash (used in) provided by investing activities
|
|
(12,989
|
)
|
|
(20,836
|
)
|
|
2,004
|
|
|||
|
Financing activities
|
|
|
|
|
|
|
||||||
|
Issue of Class A ordinary shares, net of forfeitures
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Net proceeds from exercise of stock options
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Short-swing sale profit from shareholder
|
|
—
|
|
|
83
|
|
|
—
|
|
|||
|
Repurchase of Class A ordinary shares
|
|
—
|
|
|
(17,692
|
)
|
|
—
|
|
|||
|
Net cash (used in) provided by financing activities
|
|
—
|
|
|
(17,609
|
)
|
|
—
|
|
|||
|
Net increase (decrease) in cash and cash equivalents
|
|
—
|
|
|
5
|
|
|
(4
|
)
|
|||
|
Cash and cash equivalents at beginning of the year
|
|
6
|
|
|
1
|
|
|
5
|
|
|||
|
Cash and cash equivalents at end of the year
|
|
$
|
6
|
|
|
$
|
6
|
|
|
$
|
1
|
|
|
Supplementary information
|
|
|
|
|
|
|
||||||
|
Non cash consideration from (to) subsidiaries, net
|
|
$
|
72
|
|
|
$
|
(227
|
)
|
|
$
|
(158
|
)
|
|
Year
|
Segment
|
Deferred
acquisition costs, net |
Reserves
for losses and loss adjustment expenses – gross |
Unearned
premiums – gross |
Net
premiums earned |
Net
investment income (loss) |
Net losses,
and loss adjustment expenses |
Amortization
of deferred acquisition costs |
Other
operating expenses |
Gross
premiums written |
||||||||||||||||||
|
2016
|
Property & Casualty
|
$
|
61,022
|
|
$
|
306,641
|
|
$
|
222,527
|
|
$
|
513,118
|
|
$
|
76,183
|
|
$
|
380,815
|
|
$
|
134,534
|
|
$
|
25,808
|
|
$
|
536,072
|
|
|
2015
|
Property & Casualty
|
$
|
59,823
|
|
$
|
305,997
|
|
$
|
211,954
|
|
$
|
408,387
|
|
$
|
(281,924
|
)
|
$
|
317,097
|
|
$
|
116,207
|
|
$
|
23,434
|
|
$
|
502,124
|
|
|
2014
|
Property & Casualty
|
$
|
34,420
|
|
$
|
264,243
|
|
$
|
128,736
|
|
$
|
354,240
|
|
$
|
122,575
|
|
$
|
234,986
|
|
$
|
107,665
|
|
$
|
24,500
|
|
$
|
324,023
|
|
|
Year
|
Segment
|
|
Direct gross
premiums |
|
Premiums
ceded to other companies |
|
Premiums
assumed from other companies |
|
Net written premiums
|
|
Percentage of
amount assumed to net |
|||||||||
|
2016
|
Property & Casualty
|
|
$
|
—
|
|
|
$
|
10,015
|
|
|
$
|
536,072
|
|
|
$
|
526,057
|
|
|
102
|
%
|
|
2015
|
Property & Casualty
|
|
$
|
—
|
|
|
$
|
9,001
|
|
|
$
|
502,124
|
|
|
$
|
493,123
|
|
|
102
|
%
|
|
2014
|
Property & Casualty
|
|
$
|
—
|
|
|
$
|
13,493
|
|
|
$
|
324,023
|
|
|
$
|
310,530
|
|
|
104
|
%
|
|
Exhibit Number
|
Description of Exhibit
|
|
3.1
|
Third Amended and Restated Memorandum and Articles of Association as revised by special resolution on July 10, 2008 (incorporated by reference to Exhibit 3.1 of the Company’s Form 10-Q filed on August 7, 2008)
|
|
|
4.1
|
Form of Specimen Certificate of Class A ordinary shares (incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement No. 333-139993)
|
|
|
4.2
|
Share Purchase Option, dated August 11, 2004, by and between the Registrant and First International Capital Holdings, Ltd. (incorporated by reference to Exhibit 4.2 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.1
|
Form of Securities Purchase Agreement for Class A ordinary shares by and between the Registrant and each of the subscribers thereto (incorporated by reference to Exhibit 10.2 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.2 (1)
|
Greenlight Capital Re, Ltd. Third Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Exhibit 10.19 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.3 (1)
|
Form of Restricted Stock Award Agreement by and between the Registrant and the Grantee (incorporated by reference to Exhibit 10.6 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.4 (1)
|
Form of Stock Option Agreement (incorporated by reference to Exhibit 10.7 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.5 (1)
|
Greenlight Capital Re, Ltd. Form of Directors’ Restricted Stock Award (incorporated by reference to Exhibit 10.20 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.6 (1)
|
Greenlight Capital Re, Ltd. Form of Employees’ Restricted Stock Award (incorporated by reference to Exhibit 10.21 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.7
|
Form of Shareholders’ Agreement, dated August 11, 2004, by and among the Registrant and each of the subscribers (incorporated by reference to Exhibit 10.8 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.8
|
Form of Deed of Indemnity between the Registrant and each of its directors and certain of its officers (incorporated by reference to Exhibit 10.11 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.9 (1)
|
Amended and Restated Employment Agreement, dated as of December 30, 2008, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Tim Courtis (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed on January 2, 2009)
|
|
|
10.10 (1)
|
Concurrent Private Placement Stock Purchase Agreement for Class B Ordinary Shares, dated January 11, 2007, by and between the Company and David Einhorn (incorporated by reference to Exhibit 10.16 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.11
|
Service Agreement, dated as of February 21, 2007, between DME Advisors, LP and Greenlight Capital Re, Ltd. (incorporated by reference to Exhibit 10.17 of the Company’s Registration Statement No. 333-139993)
|
|
|
10.12 (1)
|
Amendment No. 1, dated February 18, 2009, to the Amended and Restated Employment Agreement, dated as of December 30, 2008, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Tim Courtis (incorporated by reference to Exhibit 10.26 of the Company’s Form 10-K filed on February 23, 2009)
|
|
|
10.14 (1)
|
Greenlight Capital Re, Ltd. Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on May 4, 2010)
|
|
|
10.15
|
Amended and Restated Letter of Credit Agreement, executed June 17, 2010, between Greenlight Reinsurance, Ltd. and Butterfield Bank (Cayman) Limited (incorporated by reference to Exhibit 10.3 of the Company’s Form 10-Q filed on August 2, 2010)
|
|
|
10.17
|
Letter of Understanding, dated June 10, 2010, between Greenlight Reinsurance, Ltd. and Citibank, N.A (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on August 2, 2010)
|
|
|
10.18
|
Letter of Credit Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc. (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on November 2, 2010)
|
|
|
10.19
|
Master Reimbursement Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc (incorporated by reference to Exhibit 10.2 of the Company’s Form 10-Q filed on November 2, 2010)
|
|
|
10.20
|
Reinsurance Deposit Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc. (incorporated by reference to Exhibit 10.3 of the Company’s Form 10-Q filed on November 2, 2010)
|
|
|
10.22
|
Letter of Credit Agreement, effective as of February 3, 2011, between Greenlight Reinsurance, Ltd. and JPMorgan Chase Bank N.A. (incorporated by reference to Exhibit 10.38 of the Company’s Form 10-K filed on February 22, 2011)
|
|
|
10.23 (1)
|
Amended and Restated Employment Agreement, dated July 26, 2012, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Barton Hedges (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on July 30, 2012)
|
|
|
10.24 (1)
|
Employment Agreement, dated August 15, 2006, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Brendan Barry (incorporated by reference to Exhibit 10.24 of the Company’s Form 10-K filed on February 21, 2012)
|
|
|
10.27
|
Amended letter of credit agreement, effective as of December 16, 2011, between Greenlight Reinsurance, Ltd. and JPMorgan Chase Bank N.A. (incorporated by reference to Exhibit 10.27 of the Company’s Form 10-K filed on February 21, 2012)
|
|
|
10.30 (1)
|
Employment Agreement, dated July 31, 2014, by and among Greenlight Reinsurance, Ltd. and James McNichols (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on November 3, 2014)
|
|
|
10.31
|
Amendment Letter Agreement between Greenlight Reinsurance, Ltd. and Butterfield Bank (Cayman) Limited, effective June 1, 2015, amending the Amended and Restated Letter of Credit Agreement dated June 17, 2010 (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on August 3, 2015)
|
|
|
10.32
|
Amended and Restated Letter of Credit Facility Agreement, dated May 7, 2015 between Greenlight Reinsurance, Ltd. and Bank of America, N.A., amending the Amended Letter of Credit Facility Agreement dated December 16, 2011 (incorporated by reference to Exhibit 10.2 of the Company’s Form 10-Q filed on August 3, 2015)
|
|
|
10.33
|
Letter Agreement between Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, Ltd., DME Advisors, LLC and DME Advisors, LP., dated June 17, 2015 (incorporated by reference to Exhibit 10.3 of the Company’s Form 10-Q filed on August 3, 2015)
|
|
|
10.34
|
Third Amended and Restated Agreement by and among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company, Greenlight Capital Re, Ltd. (for limited purposes), DME Advisors, LLC and DME Advisors, LP (for limited purposes), dated as of September 30, 2016 and effective as of January 1, 2017 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on October 6, 2016).
|
|
|
10.35
|
Amended and Restated Investment Advisory Agreement among DME Advisors, LP, The Venture Among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company, and DME Advisors, LLC, Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company and DME Advisors, LLC., dated as of September 30, 2016 and effective as of January 1, 2017 (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on October 6, 2016).
|
|
|
10.36
|
Deed of Settlement and Release dated December 15, 2016, among Barton Hedges, Greenlight Capital Re, Ltd., and Greenlight Reinsurance, Ltd. (incorporated by reference to Exhibit 99.2 to the Company’s Form 8-K filed on December 19, 2016).
|
|
|
10.37
|
Consulting agreement dated December 16, 2016, among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Leonard Goldberg (incorporated by reference to Exhibit 99.3 to the Company’s Form 8-K filed on December 19, 2016).
|
|
|
12.1
|
Ratio of earnings to fixed charges and preferred share dividends.
|
|
|
21.1
|
Subsidiaries of the registrant (incorporated by reference to Exhibit 21.1 of the Company’s Form 10-K filed on February 22, 2011)
|
|
|
23.1
|
Consent of BDO USA, LLP
|
|
|
31.1
|
Certification of the Chief Executive Officer of Greenlight Capital Re, Ltd. filed herewith pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2
|
Certification of the Chief Financial Officer of Greenlight Capital Re, Ltd. filed herewith pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
32.1
|
Certification of the Chief Executive Officer of Greenlight Capital Re, Ltd. furnished herewith pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
32.2
|
Certification of the Chief Financial Officer of Greenlight Capital Re, Ltd. furnished herewith pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
101
|
The following materials from the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Income; (iii) the Consolidated Statements of Shareholders’ Equity; (iv) the Consolidated Statements of Cash Flows; and (v) the Notes to Consolidated Financial Statements.
|
|
|
|
|
|
|
(1
|
)
|
Management contract or compensatory plan or arrangement.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|